{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,27]],"date-time":"2026-10-27T04:21:42Z","timestamp":1793074902869,"version":"4.5.0"},"reference-count":365,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Psychiatric Research"],"published-print":{"date-parts":[[2026,4]]},"DOI":"10.1016\/j.jpsychires.2026.01.050","type":"journal-article","created":{"date-parts":[[2026,1,30]],"date-time":"2026-01-30T07:41:40Z","timestamp":1769758900000},"page":"225-243","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"special_numbering":"C","title":["Microglial, astrocytic, oligodendrocyte, B-\/T-cell and neutrophil dysregulation in neuroinflammation of Alzheimer's disease and related dementias"],"prefix":"10.1016","volume":"195","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-1999-2321","authenticated-orcid":false,"given":"Asem Surindro","family":"Singh","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Afsar Raza","family":"Naqvi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Machathoibi Takhellambam","family":"Chanu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jpsychires.2026.01.050_bib1","series-title":"A double-blind Dual Study Assessing Safety and Efficacy of Buntanetap in Participants with Early AD","year":"2025"},{"key":"10.1016\/j.jpsychires.2026.01.050_bib2","article-title":"A study of Donanemab (LY3002813) in participants with early symptomatic Alzheimer's disease (TRAILBLAZER-ALZ 5)","year":"2025","journal-title":"ClinicalTrialsgov"},{"key":"10.1016\/j.jpsychires.2026.01.050_bib3","series-title":"People with Parkinson's","article-title":"A study to assess the safety of BMS-984923 compared to placebo","year":"2025"},{"key":"10.1016\/j.jpsychires.2026.01.050_bib4","article-title":"A study to evaluate safety and tolerability of different doses and efficacy of PQ912 in subjects with MCI and mild AD (VIVIAD)","year":"2025","journal-title":"ClinicalTrialsgov"},{"key":"10.1016\/j.jpsychires.2026.01.050_bib5","series-title":"A Study to Evaluate the Safety and Efficacy of CT1812 in Early Alzheimer's disease","year":"2025"},{"key":"10.1016\/j.jpsychires.2026.01.050_bib6","doi-asserted-by":"crossref","DOI":"10.3390\/ijms23020616","article-title":"Neuroinflammation: a potential risk for dementia","volume":"23","author":"Ahmad","year":"2022","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.jpsychires.2026.01.050_bib7","doi-asserted-by":"crossref","DOI":"10.3390\/cells10071605","article-title":"B cells in neuroinflammation: new perspectives and mechanistic insights","volume":"10","author":"Ahn","year":"2021","journal-title":"Cells"},{"key":"10.1016\/j.jpsychires.2026.01.050_bib8","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1016\/S0197-4580(00)00124-X","article-title":"Inflammation and Alzheimer's disease","volume":"21","author":"Akiyama","year":"2000","journal-title":"Neurobiol. Aging"},{"key":"10.1016\/j.jpsychires.2026.01.050_bib9","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2021.112193","article-title":"Arginine vasopressin and pathophysiology of COVID-19: an innovative perspective","volume":"143","author":"Al-Kuraishy","year":"2021","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.jpsychires.2026.01.050_bib10","doi-asserted-by":"crossref","DOI":"10.1002\/prp2.1063","article-title":"Pros and cons for statins use and risk of Parkinson's disease: an updated perspective","volume":"11","author":"Al-Kuraishy","year":"2023","journal-title":"Pharmacol. Res. Perspect."},{"key":"10.1016\/j.jpsychires.2026.01.050_bib11","article-title":"The role of estrogen therapy as a protective factor for Alzheimer's disease and dementia in postmenopausal women: a comprehensive review of the literature","volume":"15","author":"Ali","year":"2023","journal-title":"Cureus"},{"key":"10.1016\/j.jpsychires.2026.01.050_bib12","doi-asserted-by":"crossref","first-page":"381","DOI":"10.4049\/jimmunol.1200409","article-title":"Neutrophil cerebrovascular transmigration triggers rapid neurotoxicity through release of proteases associated with decondensed DNA","volume":"189","author":"Allen","year":"2012","journal-title":"J. Immunol."},{"key":"10.1016\/j.jpsychires.2026.01.050_bib13","doi-asserted-by":"crossref","first-page":"6923","DOI":"10.1073\/pnas.121119298","article-title":"Hyperphosphorylation induces self-assembly of tau into tangles of paired helical filaments\/straight filaments","volume":"98","author":"Alonso","year":"2001","journal-title":"Proc. Natl. Acad. Sci. U. S. A"},{"key":"10.1016\/j.jpsychires.2026.01.050_bib14","doi-asserted-by":"crossref","first-page":"975","DOI":"10.1007\/s11010-023-04771-7","article-title":"Metformin role in Parkinson's disease: a double-sword effect","volume":"479","author":"Alrouji","year":"2024","journal-title":"Mol. Cell. Biochem."},{"key":"10.1016\/j.jpsychires.2026.01.050_bib15","doi-asserted-by":"crossref","DOI":"10.3390\/molecules27134124","article-title":"Targeting microglia in Alzheimer's disease: from molecular mechanisms to potential therapeutic targets for small molecules","volume":"27","author":"Althafar","year":"2022","journal-title":"Molecules"},{"key":"10.1016\/j.jpsychires.2026.01.050_bib16","article-title":"Donanemab update: new Alzheimer's disease treatment approved by the FDA","year":"2024","journal-title":"Alzheimer Dis. Int."},{"key":"10.1016\/j.jpsychires.2026.01.050_bib17","unstructured":"Alzheimer Disease Terminated Phase 2\/3 Trials for CAD106 (DB05150). wwwgodrugbankcom."},{"key":"10.1016\/j.jpsychires.2026.01.050_bib18","article-title":"Alzheimer's Disease Acitretin Medication (ADAM)","year":"2018","journal-title":"ClinicalTrialsgov"},{"key":"10.1016\/j.jpsychires.2026.01.050_bib19","doi-asserted-by":"crossref","first-page":"1598","DOI":"10.1002\/alz.13016","article-title":"2023 Alzheimer's disease facts and figures","volume":"19","year":"2023","journal-title":"Alzheimer's Dement."},{"key":"10.1016\/j.jpsychires.2026.01.050_bib20","doi-asserted-by":"crossref","first-page":"3708","DOI":"10.1002\/alz.13809","article-title":"2024 Alzheimer's disease facts and figures","volume":"20","year":"2024","journal-title":"Alzheimer's Dement."},{"key":"10.1016\/j.jpsychires.2026.01.050_bib21","doi-asserted-by":"crossref","DOI":"10.3390\/cells12182283","article-title":"T lymphocytes and their potential role in dementia with lewy bodies","volume":"12","author":"Amin","year":"2023","journal-title":"Cells"},{"key":"10.1016\/j.jpsychires.2026.01.050_bib22","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1111\/j.1365-2567.2009.03225.x","article-title":"Inflammation in neurodegenerative diseases","volume":"129","author":"Amor","year":"2010","journal-title":"Immunology"},{"key":"10.1016\/j.jpsychires.2026.01.050_bib23","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1111\/imm.12233","article-title":"Inflammation in neurodegenerative diseases--an update","volume":"142","author":"Amor","year":"2014","journal-title":"Immunology"},{"key":"10.1016\/j.jpsychires.2026.01.050_bib24","article-title":"An efficacy and safety study of sodium oligomannate (GV-971) for the treatment of Alzheimer's disease","year":"2025","journal-title":"ClinicalTrialsgov"},{"key":"10.1016\/j.jpsychires.2026.01.050_bib25","doi-asserted-by":"crossref","first-page":"2328","DOI":"10.1111\/j.1471-4159.1992.tb10128.x","article-title":"An alternative secretase cleavage produces soluble Alzheimer amyloid precursor protein containing a potentially amyloidogenic sequence","volume":"59","author":"Anderson","year":"1992","journal-title":"J. Neurochem."},{"key":"10.1016\/j.jpsychires.2026.01.050_bib26","doi-asserted-by":"crossref","first-page":"1058","DOI":"10.1093\/brain\/awg118","article-title":"B lymphocytes in the normal brain: contrasts with HIV-associated lymphoid infiltrates and lymphomas","volume":"126","author":"Anthony","year":"2003","journal-title":"Brain"},{"key":"10.1016\/j.jpsychires.2026.01.050_bib27","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1016\/S0304-3940(03)00030-2","article-title":"Aging-related down-regulation of neprilysin, a putative beta-amyloid-degrading enzyme, in transgenic Tg2576 alzheimer-like mouse brain is accompanied by an astroglial upregulation in the vicinity of beta-amyloid plaques","volume":"339","author":"Apelt","year":"2003","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.jpsychires.2026.01.050_bib28","doi-asserted-by":"crossref","first-page":"1116","DOI":"10.1038\/nn738","article-title":"TNF alpha promotes proliferation of oligodendrocyte progenitors and remyelination","volume":"4","author":"Arnett","year":"2001","journal-title":"Nat. Neurosci."},{"key":"10.1016\/j.jpsychires.2026.01.050_bib29","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1186\/1742-2094-9-83","article-title":"Maternal immune activation by poly I:C induces expression of cytokines IL-1beta and IL-13, chemokine MCP-1 and colony stimulating factor VEGF in fetal mouse brain","volume":"9","author":"Arrode-Bruses","year":"2012","journal-title":"J. Neuroinflammation"},{"key":"10.1016\/j.jpsychires.2026.01.050_bib30","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1007\/s11910-020-01085-9","article-title":"The relation of diabetes to memory function","volume":"20","author":"Arvanitakis","year":"2020","journal-title":"Curr. Neurol. Neurosci. Rep."},{"issue":"2025","key":"10.1016\/j.jpsychires.2026.01.050_bib31","first-page":"1","article-title":"Alzheimer's disease facts and figures","volume":"21","year":"2025","journal-title":"Alzheimer's Dementia"},{"key":"10.1016\/j.jpsychires.2026.01.050_bib32","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1152\/physrev.00024.2003","article-title":"Role of tau protein in both physiological and pathological conditions","volume":"84","author":"Avila","year":"2004","journal-title":"Physiol. Rev."},{"key":"10.1016\/j.jpsychires.2026.01.050_bib33","doi-asserted-by":"crossref","DOI":"10.1016\/j.brainres.2024.149245","article-title":"Novel insights into the role of TREM2 in cerebrovascular diseases","volume":"1846","author":"Awuah","year":"2025","journal-title":"Brain Res."},{"key":"10.1016\/j.jpsychires.2026.01.050_bib35","doi-asserted-by":"crossref","first-page":"1311","DOI":"10.1046\/j.1471-4159.2002.01091.x","article-title":"Characterization of chemokines and their receptors in the central nervous system: physiopathological implications","volume":"82","author":"Bajetto","year":"2002","journal-title":"J. Neurochem."},{"key":"10.1016\/j.jpsychires.2026.01.050_bib36","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1016\/j.phrs.2018.01.017","article-title":"Novel targets in Alzheimer's disease: a special focus on microglia","volume":"130","author":"Balducci","year":"2018","journal-title":"Pharmacol. Res."},{"key":"10.1016\/j.jpsychires.2026.01.050_bib37","doi-asserted-by":"crossref","first-page":"506","DOI":"10.1021\/acschemneuro.0c00688","article-title":"Cholesterol in membranes facilitates aggregation of amyloid beta protein at physiologically relevant concentrations","volume":"12","author":"Banerjee","year":"2021","journal-title":"ACS Chem. Neurosci."},{"key":"10.1016\/j.jpsychires.2026.01.050_bib38","doi-asserted-by":"crossref","first-page":"2783","DOI":"10.4049\/jimmunol.1001431","article-title":"TLR and B cell receptor signals to B cells differentially program primary and memory Th1 responses to Salmonella enterica","volume":"185","author":"Barr","year":"2010","journal-title":"J. Immunol."},{"key":"10.1016\/j.jpsychires.2026.01.050_bib39","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/j.neures.2011.06.004","article-title":"Astrocytic-neuronal crosstalk: implications for neuroprotection from brain injury","volume":"71","author":"Barreto","year":"2011","journal-title":"Neurosci. Res."},{"key":"10.1016\/j.jpsychires.2026.01.050_bib40","doi-asserted-by":"crossref","first-page":"7967","DOI":"10.1038\/ncomms8967","article-title":"Breaking immune tolerance by targeting Foxp3(+) regulatory T cells mitigates Alzheimer's disease pathology","volume":"6","author":"Baruch","year":"2015","journal-title":"Nat. Commun."},{"key":"10.1016\/j.jpsychires.2026.01.050_bib41","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1007\/s00011-025-02016-5","article-title":"APOE4 impairs autophagy and Abeta clearance by microglial cells","volume":"74","author":"Bassal","year":"2025","journal-title":"Inflamm. Res."},{"key":"10.1016\/j.jpsychires.2026.01.050_bib42","doi-asserted-by":"crossref","first-page":"1862","DOI":"10.1056\/NEJMoa2304430","article-title":"Two phase 3 trials of gantenerumab in early Alzheimer's disease","volume":"389","author":"Bateman","year":"2023","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.jpsychires.2026.01.050_bib43","doi-asserted-by":"crossref","first-page":"871","DOI":"10.1152\/physrev.2001.81.2.871","article-title":"Biology of oligodendrocyte and myelin in the mammalian central nervous system","volume":"81","author":"Baumann","year":"2001","journal-title":"Physiol. Rev."},{"key":"10.1016\/j.jpsychires.2026.01.050_bib44","doi-asserted-by":"crossref","DOI":"10.3390\/molecules27248823","article-title":"BACE1 inhibitors for Alzheimer's disease: the past, present and any future?","volume":"27","author":"Bazzari","year":"2022","journal-title":"Molecules"},{"key":"10.1016\/j.jpsychires.2026.01.050_bib45","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1002\/glia.22432","article-title":"Dynamic changes in myelin aberrations and oligodendrocyte generation in chronic amyloidosis in mice and men","volume":"61","author":"Behrendt","year":"2013","journal-title":"Glia"},{"key":"10.1016\/j.jpsychires.2026.01.050_bib46","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1007\/s40266-013-0108-6","article-title":"Successes and failures for drugs in late-stage development for Alzheimer's disease","volume":"30","author":"Berk","year":"2013","journal-title":"Drugs Aging"},{"key":"10.1016\/j.jpsychires.2026.01.050_bib47","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2024.1362995","article-title":"Dysfunctional mitochondria, disrupted levels of reactive oxygen species, and autophagy in B cells from common variable immunodeficiency patients","volume":"15","author":"Berman-Riu","year":"2024","journal-title":"Front. Immunol."},{"key":"10.1016\/j.jpsychires.2026.01.050_bib48","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1038\/s41582-021-00549-x","article-title":"Peripheral and central immune system crosstalk in Alzheimer disease - a research prospectus","volume":"17","author":"Bettcher","year":"2021","journal-title":"Nat. Rev. Neurol."},{"key":"10.1016\/j.jpsychires.2026.01.050_bib49","doi-asserted-by":"crossref","DOI":"10.1016\/j.jstrokecerebrovasdis.2021.105864","article-title":"Emerging concepts in vascular dementia: a review","volume":"30","author":"Bir","year":"2021","journal-title":"J. Stroke Cerebrovasc. Dis."},{"key":"10.1016\/j.jpsychires.2026.01.050_bib50","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1007\/s00281-016-0615-8","article-title":"Potential importance of B cells in aging and aging-associated neurodegenerative diseases","volume":"39","author":"Biragyn","year":"2017","journal-title":"Semin. Immunopathol."},{"key":"10.1016\/j.jpsychires.2026.01.050_bib52","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1038\/s41419-021-03446-9","article-title":"The immune-inflammatory response of oligodendrocytes in a murine model of preterm white matter injury: the role of TLR3 activation","volume":"12","author":"Boccazzi","year":"2021","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.jpsychires.2026.01.050_bib53","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1038\/s41390-018-0208-4","article-title":"Neuroinflammation in preterm babies and autism spectrum disorders","volume":"85","author":"Bokobza","year":"2019","journal-title":"Pediatr. Res."},{"key":"10.1016\/j.jpsychires.2026.01.050_bib54","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1007\/s00401-022-02418-3","article-title":"Donanemab detects a minor fraction of amyloid-beta plaques in post-mortem brain tissue of patients with Alzheimer's disease and Down syndrome","volume":"143","author":"Bouter","year":"2022","journal-title":"Acta Neuropathol."},{"key":"10.1016\/j.jpsychires.2026.01.050_bib55","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1007\/s00401-009-0601-5","article-title":"Oligodendrocytes: biology and pathology","volume":"119","author":"Bradl","year":"2010","journal-title":"Acta Neuropathol."},{"key":"10.1016\/j.jpsychires.2026.01.050_bib56","article-title":"Impacts of FDA approval and Medicare restriction on antiamyloid therapies for Alzheimer's disease: patient outcomes, healthcare costs, and drug development","volume":"20","author":"Brockmann","year":"2023","journal-title":"Lancet Reg. Health Am"},{"key":"10.1016\/j.jpsychires.2026.01.050_bib57","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1016\/j.immuni.2015.06.012","article-title":"Genetic cell ablation reveals clusters of local self-renewing microglia in the mammalian central nervous system","volume":"43","author":"Bruttger","year":"2015","journal-title":"Immunity"},{"key":"10.1016\/j.jpsychires.2026.01.050_bib58","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1186\/s12974-020-01968-1","article-title":"The immune system on the TRAIL of Alzheimer's disease","volume":"17","author":"Burgaletto","year":"2020","journal-title":"J. Neuroinflammation"},{"key":"10.1016\/j.jpsychires.2026.01.050_bib59","doi-asserted-by":"crossref","first-page":"1183","DOI":"10.1038\/s41593-020-0687-6","article-title":"Synergy between amyloid-beta and tau in Alzheimer's disease","volume":"23","author":"Busche","year":"2020","journal-title":"Nat. Neurosci."},{"key":"10.1016\/j.jpsychires.2026.01.050_bib60","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1089\/ars.2012.5027","article-title":"Amyloid beta-peptide (1-42)-induced oxidative stress in Alzheimer disease: importance in disease pathogenesis and progression","volume":"19","author":"Butterfield","year":"2013","journal-title":"Antioxidants Redox Signal."},{"key":"10.1016\/j.jpsychires.2026.01.050_bib61","doi-asserted-by":"crossref","first-page":"31","DOI":"10.2174\/1872214810666160615102809","article-title":"Alterations in glucose metabolism in Alzheimer's disease","volume":"10","author":"Calsolaro","year":"2016","journal-title":"Recent Pat. Endocr. Metab. Immune Drug Discov."},{"key":"10.1016\/j.jpsychires.2026.01.050_bib62","doi-asserted-by":"crossref","first-page":"648","DOI":"10.1016\/j.it.2019.05.003","article-title":"Biological roles of neutrophil-derived granule proteins and cytokines","volume":"40","author":"Cassatella","year":"2019","journal-title":"Trends Immunol."},{"key":"10.1016\/j.jpsychires.2026.01.050_bib63","doi-asserted-by":"crossref","first-page":"3749","DOI":"10.1523\/JNEUROSCI.2352-20.2021","article-title":"Amyloid beta clearance is disrupted by depletion of low-density lipoprotein receptor-related protein 4 (LRP4) in astrocytes","volume":"41","author":"Cavieres-Lepe","year":"2021","journal-title":"J. Neurosci."},{"key":"10.1016\/j.jpsychires.2026.01.050_bib64","doi-asserted-by":"crossref","DOI":"10.1155\/2015\/521957","article-title":"Functional and phenotypic plasticity of CD4(+) T cell subsets","volume":"2015","author":"Caza","year":"2015","journal-title":"BioMed Res. Int."},{"key":"10.1016\/j.jpsychires.2026.01.050_bib66","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1186\/s12974-023-02853-3","article-title":"Tau and neuroinflammation in Alzheimer's disease: interplay mechanisms and clinical translation","volume":"20","author":"Chen","year":"2023","journal-title":"J. Neuroinflammation"},{"key":"10.1016\/j.jpsychires.2026.01.050_bib67","doi-asserted-by":"crossref","first-page":"3391","DOI":"10.3892\/mmr.2016.4948","article-title":"Role of neuroinflammation in neurodegenerative diseases","volume":"13","author":"Chen","year":"2016","journal-title":"Mol. Med. Rep."},{"key":"10.1016\/j.jpsychires.2026.01.050_bib68","article-title":"Association of sickle cell trait with measures of cognitive function and dementia in African Americans","volume":"16","author":"Chen","year":"2019","journal-title":"eNeurological Sci."},{"key":"10.1016\/j.jpsychires.2026.01.050_bib69","doi-asserted-by":"crossref","first-page":"668","DOI":"10.1038\/s41586-023-05788-0","article-title":"Microglia-mediated T cell infiltration drives neurodegeneration in tauopathy","volume":"615","author":"Chen","year":"2023","journal-title":"Nature"},{"key":"10.1016\/j.jpsychires.2026.01.050_bib70","article-title":"Minocycline reduces neuroinflammation but does not ameliorate neuron loss in a mouse model of neurodegeneration","volume":"5","author":"Cheng","year":"2015","journal-title":"Sci. Rep."},{"key":"10.1016\/j.jpsychires.2026.01.050_bib71","doi-asserted-by":"crossref","first-page":"1294","DOI":"10.1093\/brain\/awae029","article-title":"Prolonged myelin deficits contribute to neuron loss and functional impairments after ischaemic stroke","volume":"147","author":"Cheng","year":"2024","journal-title":"Brain"},{"key":"10.1016\/j.jpsychires.2026.01.050_bib72","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/j.stem.2019.06.001","article-title":"Is Alzheimer's disease a neurogenesis disorder?","volume":"25","author":"Choi","year":"2019","journal-title":"Cell Stem Cell"},{"key":"10.1016\/j.jpsychires.2026.01.050_bib73","article-title":"Human astrocytes: secretome profiles of cytokines and chemokines","volume":"9","author":"Choi","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.jpsychires.2026.01.050_bib74","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1111\/imr.12671","article-title":"Dynamic balance of pro- and anti-inflammatory signals controls disease and limits pathology","volume":"285","author":"Cicchese","year":"2018","journal-title":"Immunol. Rev."},{"key":"10.1016\/j.jpsychires.2026.01.050_bib75","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1007\/s00401-020-02193-z","article-title":"TREM2 activation on microglia promotes myelin debris clearance and remyelination in a model of multiple sclerosis","volume":"140","author":"Cignarella","year":"2020","journal-title":"Acta Neuropathol."},{"key":"10.1016\/j.jpsychires.2026.01.050_bib76","doi-asserted-by":"crossref","first-page":"121","DOI":"10.3389\/fncel.2014.00121","article-title":"Fractalkine\/CX3CR1 signaling during neuropathic pain","volume":"8","author":"Clark","year":"2014","journal-title":"Front. Cell. Neurosci."},{"key":"10.1016\/j.jpsychires.2026.01.050_bib77","doi-asserted-by":"crossref","first-page":"580","DOI":"10.1038\/s41577-023-00837-1","article-title":"The biology of TREM receptors","volume":"23","author":"Colonna","year":"2023","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.jpsychires.2026.01.050_bib78","article-title":"COMMETS- combination MCI metabolic syndrome","year":"2025","journal-title":"ClinicalTrialsgov"},{"key":"10.1016\/j.jpsychires.2026.01.050_bib79","article-title":"Lilly voluntarily terminates phase II study for LY2886721, a beta secretase inhibitor, being investigated as a treatment for Alzheimer's disease","author":"Company","year":"2013","journal-title":"PRNewswire"},{"key":"10.1016\/j.jpsychires.2026.01.050_bib80","series-title":"Leading to Decision to Discontinue These Trials","article-title":"Update on Phase 3 clinical trials of lanabecestat for Alzheimer's disease: independent data monitoring committee advises lanabecestat is unlikely to meet primary endpoints","author":"Company","year":"2018"},{"key":"10.1016\/j.jpsychires.2026.01.050_bib81","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1002\/glia.1061","article-title":"Inducible ablation of astrocytes shows that these cells are required for neuronal survival in the adult brain","volume":"34","author":"Cui","year":"2001","journal-title":"Glia"},{"key":"10.1016\/j.jpsychires.2026.01.050_bib82","doi-asserted-by":"crossref","first-page":"362","DOI":"10.14283\/jpad.2023.30","article-title":"Lecanemab: appropriate use recommendations","volume":"10","author":"Cummings","year":"2023","journal-title":"J. Prev. Alzheimers Dis."},{"key":"10.1016\/j.jpsychires.2026.01.050_bib83","first-page":"2740","article-title":"Microglial activation correlates in vivo with both tau and amyloid in Alzheimer's disease","volume":"141","author":"Dani","year":"2018","journal-title":"Brain"},{"key":"10.1016\/j.jpsychires.2026.01.050_bib84","doi-asserted-by":"crossref","first-page":"752","DOI":"10.1038\/nn1472","article-title":"ATP mediates rapid microglial response to local brain injury in vivo","volume":"8","author":"Davalos","year":"2005","journal-title":"Nat. Neurosci."},{"key":"10.1016\/j.jpsychires.2026.01.050_bib85","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1093\/cei\/uxac090","article-title":"Cytokine production by human B cells: role in health and autoimmune disease","volume":"210","author":"de Gruijter","year":"2022","journal-title":"Clin. Exp. Immunol."},{"key":"10.1016\/j.jpsychires.2026.01.050_bib86","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1016\/0304-3940(95)11384-9","article-title":"Reciprocal control of inflammatory cytokines, IL-1 and IL-6, and beta-amyloid production in cultures","volume":"188","author":"Del Bo","year":"1995","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.jpsychires.2026.01.050_bib87","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1080\/14728222.2018.1486823","article-title":"Triggering receptor expressed on myeloid cells 2 (TREM2): a potential therapeutic target for Alzheimer disease?","volume":"22","author":"Deming","year":"2018","journal-title":"Expert Opin. Ther. Targets"},{"key":"10.1016\/j.jpsychires.2026.01.050_bib88","doi-asserted-by":"crossref","DOI":"10.3390\/cells11172728","article-title":"Role of microglia and astrocytes in Alzheimer's disease: from neuroinflammation to Ca(2+) homeostasis dysregulation","volume":"11","author":"Di Benedetto","year":"2022","journal-title":"Cells"},{"key":"10.1016\/j.jpsychires.2026.01.050_bib89","article-title":"DIAN-TU Amyloid Removal Trial (ART) in dominantly inherited Alzheimer's disease (DIAN-TU)","year":"2025","journal-title":"ClinicalTrialsgov"},{"key":"10.1016\/j.jpsychires.2026.01.050_bib90","article-title":"Challenges and progress in research, diagnostics, and therapeutics in Alzheimer's disease and related dementias","volume":"8","author":"Dokholyan","year":"2022","journal-title":"Alzheimer's Dement."},{"key":"10.1016\/j.jpsychires.2026.01.050_bib91","series-title":"An Opportunity to Prevent Dementia. A Study of Potential Disease Modifying Treatments in Individuals at Risk for or with a Type of Early Onset Alzheimer's disease Caused by a Genetic Mutation. (DIAN-TU)","year":"2025"},{"key":"10.1016\/j.jpsychires.2026.01.050_bib92","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1056\/NEJMoa1210951","article-title":"A phase 3 trial of semagacestat for treatment of Alzheimer's disease","volume":"369","author":"Doody","year":"2013","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.jpsychires.2026.01.050_bib93","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1007\/s12264-013-1422-z","article-title":"Apolipoprotein E, amyloid-beta, and neuroinflammation in Alzheimer's disease","volume":"30","author":"Dorey","year":"2014","journal-title":"Neurosci. Bull."},{"key":"10.1016\/j.jpsychires.2026.01.050_bib94","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1177\/10738584211024907","article-title":"T cells: a growing universe of roles in neurodegenerative diseases","volume":"28","author":"Dressman","year":"2022","journal-title":"Neuroscientist"},{"key":"10.1016\/j.jpsychires.2026.01.050_bib95","doi-asserted-by":"crossref","first-page":"6092","DOI":"10.4049\/jimmunol.178.10.6092","article-title":"Distinct effector cytokine profiles of memory and naive human B cell subsets and implication in multiple sclerosis","volume":"178","author":"Duddy","year":"2007","journal-title":"J. Immunol."},{"key":"10.1016\/j.jpsychires.2026.01.050_bib96","doi-asserted-by":"crossref","first-page":"339","DOI":"10.3233\/JAD-210065","article-title":"Plasma apolipoprotein E3 and glucose levels are associated in APOE varepsilon3\/varepsilon4 carriers","volume":"81","author":"Edlund","year":"2021","journal-title":"J. Alzheimers Dis."},{"key":"10.1016\/j.jpsychires.2026.01.050_bib97","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1186\/s13195-019-0520-1","article-title":"Further analyses of the safety of verubecestat in the phase 3 EPOCH trial of mild-to-moderate Alzheimer's disease","volume":"11","author":"Egan","year":"2019","journal-title":"Alzheimers Res. Ther."},{"key":"10.1016\/j.jpsychires.2026.01.050_bib98","series-title":"Eisai And Biogen to Discontinue Phase III Clinical Studies Of BACE Inhibitor Elenbecestat In Early Alzheimer's Disease [news release], Discontinuation of studies based on Data Safety Monitoring Board recommendation","author":"Eisai","year":"2019"},{"key":"10.1016\/j.jpsychires.2026.01.050_bib99","doi-asserted-by":"crossref","first-page":"1254","DOI":"10.7150\/ijbs.4679","article-title":"Interleukin-6, a major cytokine in the central nervous system","volume":"8","author":"Erta","year":"2012","journal-title":"Int. J. Biol. Sci."},{"key":"10.1016\/j.jpsychires.2026.01.050_bib100","article-title":"Evaluation of safety of contraloid acetate in patients with mild cognitive impairment due to Alzheimer's disease","year":"2022","journal-title":"ClinicalTrialsgov"},{"key":"10.1016\/j.jpsychires.2026.01.050_bib101","doi-asserted-by":"crossref","first-page":"1349","DOI":"10.1001\/jama.1997.03550160069041","article-title":"Effects of age, sex, and ethnicity on the association between apolipoprotein E genotype and Alzheimer disease. A meta-analysis. APOE and Alzheimer disease Meta analysis consortium","volume":"278","author":"Farrer","year":"1997","journal-title":"JAMA"},{"key":"10.1016\/j.jpsychires.2026.01.050_bib102","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1186\/s12974-020-01980-5","article-title":"Engagement of TREM2 by a novel monoclonal antibody induces activation of microglia and improves cognitive function in Alzheimer's disease models","volume":"18","author":"Fassler","year":"2021","journal-title":"J. Neuroinflammation"},{"key":"10.1016\/j.jpsychires.2026.01.050_bib103","doi-asserted-by":"crossref","first-page":"1047","DOI":"10.1152\/physrev.00015.2020","article-title":"The complexity of Alzheimer's disease: an evolving puzzle","volume":"101","author":"Ferrari","year":"2021","journal-title":"Physiol. Rev."},{"key":"10.1016\/j.jpsychires.2026.01.050_bib104","doi-asserted-by":"crossref","first-page":"1563","DOI":"10.1212\/01.WNL.0000159743.08996.99","article-title":"Effects of Abeta immunization (AN1792) on MRI measures of cerebral volume in Alzheimer disease","volume":"64","author":"Fox","year":"2005","journal-title":"Neurology"},{"key":"10.1016\/j.jpsychires.2026.01.050_bib105","doi-asserted-by":"crossref","first-page":"37","DOI":"10.3389\/fnins.2018.00037","article-title":"Challenges for Alzheimer's disease therapy: insights from novel mechanisms beyond memory defects","volume":"12","author":"Frozza","year":"2018","journal-title":"Front. Neurosci."},{"key":"10.1016\/j.jpsychires.2026.01.050_bib106","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1186\/s13195-017-0262-x","article-title":"Association between blood pressure and Alzheimer disease measured up to 27 years prior to diagnosis: the HUNT study","volume":"9","author":"Gabin","year":"2017","journal-title":"Alzheimers Res. Ther."},{"key":"10.1016\/j.jpsychires.2026.01.050_bib107","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1111\/j.1750-3639.2012.00595.x","article-title":"Decreased oligodendrocyte nuclear diameter in Alzheimer's disease and lewy body dementia","volume":"22","author":"Gagyi","year":"2012","journal-title":"Brain Pathol."},{"key":"10.1016\/j.jpsychires.2026.01.050_bib108","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1038\/s41392-023-01588-0","article-title":"Microglia in neurodegenerative diseases: mechanism and potential therapeutic targets","volume":"8","author":"Gao","year":"2023","journal-title":"Signal Transduct. Targeted Ther."},{"key":"10.1016\/j.jpsychires.2026.01.050_bib109","doi-asserted-by":"crossref","first-page":"164","DOI":"10.35772\/ghm.2024.01033","article-title":"BACE1 inhibitor drugs for the treatment of Alzheimer's disease: lessons learned, challenges to overcome, and future prospects(dagger)","volume":"6","author":"Ghosh","year":"2024","journal-title":"Glob. Health Med."},{"key":"10.1016\/j.jpsychires.2026.01.050_bib110","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1126\/science.1194637","article-title":"Fate mapping analysis reveals that adult microglia derive from primitive macrophages","volume":"330","author":"Ginhoux","year":"2010","journal-title":"Science"},{"key":"10.1016\/j.jpsychires.2026.01.050_bib111","doi-asserted-by":"crossref","first-page":"918","DOI":"10.1016\/j.cell.2010.02.016","article-title":"Mechanisms underlying inflammation in neurodegeneration","volume":"140","author":"Glass","year":"2010","journal-title":"Cell"},{"key":"10.1016\/j.jpsychires.2026.01.050_bib112","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1186\/s13195-015-0126-1","article-title":"Post-mortem analysis of neuroinflammatory changes in human Alzheimer's disease","volume":"7","author":"Gomez-Nicola","year":"2015","journal-title":"Alzheimers Res. Ther."},{"key":"10.1016\/j.jpsychires.2026.01.050_bib113","doi-asserted-by":"crossref","first-page":"2321","DOI":"10.2174\/092986708785909111","article-title":"Hyperphosphorylation of microtubule-associated protein tau: a promising therapeutic target for Alzheimer disease","volume":"15","author":"Gong","year":"2008","journal-title":"Curr. Med. Chem."},{"key":"10.1016\/j.jpsychires.2026.01.050_bib114","article-title":"Role of tumor necrosis factor-alpha in the central nervous system: a focus on autoimmune disorders","volume":"14","author":"Gonzalez","year":"2023","journal-title":"Front. Immunol."},{"key":"10.1016\/j.jpsychires.2026.01.050_bib115","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1186\/s12974-014-0201-8","article-title":"T-cell-mediated regulation of neuroinflammation involved in neurodegenerative diseases","volume":"11","author":"Gonzalez","year":"2014","journal-title":"J. Neuroinflammation"},{"key":"10.1016\/j.jpsychires.2026.01.050_bib116","doi-asserted-by":"crossref","first-page":"7611","DOI":"10.1073\/pnas.86.19.7611","article-title":"Brain interleukin 1 and S-100 immunoreactivity are elevated in Down syndrome and Alzheimer disease","volume":"86","author":"Griffin","year":"1989","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.jpsychires.2026.01.050_bib117","doi-asserted-by":"crossref","first-page":"549","DOI":"10.3389\/fneur.2018.00549","article-title":"Roles of microglial and monocyte chemokines and their receptors in regulating alzheimer's disease-associated amyloid-beta and tau pathologies","volume":"9","author":"Guedes","year":"2018","journal-title":"Front. Neurol."},{"key":"10.1016\/j.jpsychires.2026.01.050_bib118","doi-asserted-by":"crossref","DOI":"10.1212\/NXI.0000000000000431","article-title":"Proinflammatory B-cell profile in the early phases of MS predicts an active disease","volume":"5","author":"Guerrier","year":"2018","journal-title":"Neurol. Neuroimmunol. Neuroinflamm."},{"key":"10.1016\/j.jpsychires.2026.01.050_bib119","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1007\/s00401-017-1707-9","article-title":"Roles of tau protein in health and disease","volume":"133","author":"Guo","year":"2017","journal-title":"Acta Neuropathol."},{"key":"10.1016\/j.jpsychires.2026.01.050_bib120","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1186\/s13024-020-00391-7","article-title":"Molecular and cellular mechanisms underlying the pathogenesis of Alzheimer's disease","volume":"15","author":"Guo","year":"2020","journal-title":"Mol. Neurodegener."},{"key":"10.1016\/j.jpsychires.2026.01.050_bib121","doi-asserted-by":"crossref","first-page":"6473","DOI":"10.1523\/JNEUROSCI.1419-07.2007","article-title":"Synaptic islands defined by the territory of a single astrocyte","volume":"27","author":"Halassa","year":"2007","journal-title":"J. Neurosci."},{"key":"10.1016\/j.jpsychires.2026.01.050_bib122","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1016\/S0896-6273(04)00007-8","article-title":"PKC signaling mediates global enhancement of excitatory synaptogenesis in neurons triggered by local contact with astrocytes","volume":"41","author":"Hama","year":"2004","journal-title":"Neuron"},{"key":"10.1016\/j.jpsychires.2026.01.050_bib123","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1016\/j.nurt.2010.07.003","article-title":"Reactive astrocytes as therapeutic targets for CNS disorders","volume":"7","author":"Hamby","year":"2010","journal-title":"Neurotherapeutics"},{"key":"10.1016\/j.jpsychires.2026.01.050_bib124","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1002\/glia.10161","article-title":"Microglia as a source and target of cytokines","volume":"40","author":"Hanisch","year":"2002","journal-title":"Glia"},{"key":"10.1016\/j.jpsychires.2026.01.050_bib125","doi-asserted-by":"crossref","first-page":"2249","DOI":"10.1016\/j.neurobiolaging.2014.03.026","article-title":"Neuronal driven pre-plaque inflammation in a transgenic rat model of Alzheimer's disease","volume":"35","author":"Hanzel","year":"2014","journal-title":"Neurobiol. Aging"},{"key":"10.1016\/j.jpsychires.2026.01.050_bib126","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1002\/glia.10178","article-title":"Astrocytic expression of the Alzheimer's disease beta-secretase (BACE1) is stimulus-dependent","volume":"41","author":"Hartlage-Rubsamen","year":"2003","journal-title":"Glia"},{"key":"10.1016\/j.jpsychires.2026.01.050_bib127","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1016\/S0304-3940(02)00888-1","article-title":"Pathological relationships between microglial cell activity and tau and amyloid beta protein in patients with Alzheimer's disease","volume":"331","author":"Hayes","year":"2002","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.jpsychires.2026.01.050_bib128","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1016\/j.neuron.2022.12.032","article-title":"ApoE4 makes microglia trem(2)bling","volume":"111","author":"Heneka","year":"2023","journal-title":"Neuron"},{"key":"10.1016\/j.jpsychires.2026.01.050_bib129","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1016\/S1474-4422(15)70016-5","article-title":"Neuroinflammation in Alzheimer's disease","volume":"14","author":"Heneka","year":"2015","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.jpsychires.2026.01.050_bib130","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1016\/S1474-4422(15)70016-5","article-title":"Neuroinflammation in Alzheimer's disease","volume":"14","author":"Heneka","year":"2015","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.jpsychires.2026.01.050_bib131","doi-asserted-by":"crossref","DOI":"10.1038\/s41380-025-02939-9","article-title":"Neuroinflammatory fluid biomarkers in patients with Alzheimer's disease: a systematic literature review","author":"Heneka","year":"2025","journal-title":"Mol. Psychiatr."},{"key":"10.1016\/j.jpsychires.2026.01.050_bib132","doi-asserted-by":"crossref","first-page":"8354","DOI":"10.1523\/JNEUROSCI.0616-08.2008","article-title":"Microglial dysfunction and defective beta-amyloid clearance pathways in aging Alzheimer's disease mice","volume":"28","author":"Hickman","year":"2008","journal-title":"J. Neurosci."},{"key":"10.1016\/j.jpsychires.2026.01.050_bib133","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1111\/j.1749-6632.2003.tb07478.x","article-title":"The role of glial reaction and inflammation in Parkinson's disease","volume":"991","author":"Hirsch","year":"2003","journal-title":"Ann. N. Y. Acad. Sci."},{"key":"10.1016\/j.jpsychires.2026.01.050_bib134","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-017-11103-5","article-title":"Astrocytes and oligodendrocytes in grey and white matter regions of the brain metabolize fatty acids","volume":"7","author":"Hofmann","year":"2017","journal-title":"Sci. Rep."},{"key":"10.1016\/j.jpsychires.2026.01.050_bib135","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1038\/s41582-023-00884-1","article-title":"Molecular biomarkers for vascular cognitive impairment and dementia","volume":"19","author":"Hosoki","year":"2023","journal-title":"Nat. Rev. Neurol."},{"key":"10.1016\/j.jpsychires.2026.01.050_bib136","article-title":"Association of peripheral blood cell profile with Alzheimer's disease: a meta-analysis","volume":"14","author":"Huang","year":"2022","journal-title":"Front. Aging Neurosci."},{"key":"10.1016\/j.jpsychires.2026.01.050_bib137","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1186\/s12929-023-00976-6","article-title":"Clinical trials of new drugs for Alzheimer disease: a 2020-2023 update","volume":"30","author":"Huang","year":"2023","journal-title":"J. Biomed. Sci."},{"key":"10.1016\/j.jpsychires.2026.01.050_bib138","doi-asserted-by":"crossref","first-page":"2590","DOI":"10.1007\/s12035-023-03713-0","article-title":"TREM2 deficiency aggravates NLRP3 inflammasome activation and pyroptosis in MPTP-induced Parkinson's disease mice and LPS-induced BV2 cells","volume":"61","author":"Huang","year":"2024","journal-title":"Mol. Neurobiol."},{"key":"10.1016\/j.jpsychires.2026.01.050_bib139","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1007\/s00018-024-05533-4","article-title":"Innate and adaptive immunity in neurodegenerative disease","volume":"82","author":"Huang","year":"2025","journal-title":"Cell. Mol. Life Sci."},{"key":"10.1016\/j.jpsychires.2026.01.050_bib140","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/S1474-4422(14)70262-5","article-title":"Safety, tolerability, and efficacy of PBT2 in Huntington's disease: a phase 2, randomised, double-blind, placebo-controlled trial","volume":"14","year":"2015","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.jpsychires.2026.01.050_bib141","article-title":"Trends in global burden of Alzheimer's disease and other dementias attributable to high fasting plasma glucose, 1990-2021","volume":"60","author":"Ilic","year":"2024","journal-title":"Medicina (Kaunas)"},{"key":"10.1016\/j.jpsychires.2026.01.050_bib142","doi-asserted-by":"crossref","first-page":"656","DOI":"10.2174\/156720510793611592","article-title":"Tau in Alzheimer disease and related tauopathies","volume":"7","author":"Iqbal","year":"2010","journal-title":"Curr. Alzheimer Res."},{"key":"10.1016\/j.jpsychires.2026.01.050_bib143","doi-asserted-by":"crossref","DOI":"10.3390\/ijms242115805","article-title":"Role of neutrophil extracellular traps in health and disease pathophysiology: recent insights and advances","volume":"24","author":"Islam","year":"2023","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.jpsychires.2026.01.050_bib144","doi-asserted-by":"crossref","DOI":"10.3389\/fnagi.2025.1535280","article-title":"Multi-functional role of apolipoprotein E in neurodegenerative diseases","volume":"17","author":"Islam","year":"2025","journal-title":"Front. Aging Neurosci."},{"key":"10.1016\/j.jpsychires.2026.01.050_bib145","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1038\/s41577-021-00652-6","article-title":"B cells in central nervous system disease: diversity, locations and pathophysiology","volume":"22","author":"Jain","year":"2022","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.jpsychires.2026.01.050_bib146","doi-asserted-by":"crossref","first-page":"1107","DOI":"10.2967\/jnumed.119.229443","article-title":"Neuroinflammation PET imaging: current opinion and future directions","volume":"61","author":"Jain","year":"2020","journal-title":"J. Nucl. Med."},{"key":"10.1016\/j.jpsychires.2026.01.050_bib147","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1111\/eci.12072","article-title":"Alzheimer's disease and granulocyte density diversity","volume":"43","author":"Jaremo","year":"2013","journal-title":"Eur. J. Clin. Invest."},{"key":"10.1016\/j.jpsychires.2026.01.050_bib148","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1016\/j.neuropharm.2016.01.028","article-title":"TREM2 modifies microglial phenotype and provides neuroprotection in P301S tau transgenic mice","volume":"105","author":"Jiang","year":"2016","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.jpsychires.2026.01.050_bib149","doi-asserted-by":"crossref","first-page":"886","DOI":"10.1038\/nm.3639","article-title":"GABA from reactive astrocytes impairs memory in mouse models of Alzheimer's disease","volume":"20","author":"Jo","year":"2014","journal-title":"Nat. Med."},{"key":"10.1016\/j.jpsychires.2026.01.050_bib150","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1093\/brain\/aws322","article-title":"Inflammation and white matter degeneration persist for years after a single traumatic brain injury","volume":"136","author":"Johnson","year":"2013","journal-title":"Brain"},{"key":"10.1016\/j.jpsychires.2026.01.050_bib151","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0080975","article-title":"Inhibition of NADPH oxidase activation in oligodendrocytes reduces cytotoxicity following trauma","volume":"8","author":"Johnstone","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.jpsychires.2026.01.050_bib152","series-title":"New York: Garland Science 2001; Generation of Lymphocytes in Bone Marrow and Thymus","article-title":"Immunobiology: the immune system in health and disease","author":"Jr","year":"2001"},{"key":"10.1016\/j.jpsychires.2026.01.050_bib153","doi-asserted-by":"crossref","first-page":"25","DOI":"10.3389\/fnins.2018.00025","article-title":"Reconsideration of amyloid hypothesis and Tau hypothesis in Alzheimer's Disease","volume":"12","author":"Kametani","year":"2018","journal-title":"Front. Neurosci."},{"key":"10.1016\/j.jpsychires.2026.01.050_bib154","doi-asserted-by":"crossref","DOI":"10.1016\/j.phrs.2019.104580","article-title":"The role of neutrophils in neuro-immune modulation","volume":"151","author":"Kanashiro","year":"2020","journal-title":"Pharmacol. Res."},{"key":"10.1016\/j.jpsychires.2026.01.050_bib155","doi-asserted-by":"crossref","DOI":"10.3390\/jcm8020167","article-title":"White matter changes in patients with Alzheimer's Disease and associated factors","volume":"8","author":"Kao","year":"2019","journal-title":"J. Clin. Med."},{"key":"10.1016\/j.jpsychires.2026.01.050_bib156","doi-asserted-by":"crossref","first-page":"7","DOI":"10.31887\/DCNS.2019.21.1\/vharoutunian","article-title":"Is Alzheimer disease a failure of mobilizing immune defense? Lessons from cognitively fit oldest-old","volume":"21","author":"Katsel","year":"2019","journal-title":"Dialogues Clin. Neurosci."},{"key":"10.1016\/j.jpsychires.2026.01.050_bib157","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1212\/WNL.0000000000001831","article-title":"Multiple pathologies are common and related to dementia in the oldest-old: the 90+ study","volume":"85","author":"Kawas","year":"2015","journal-title":"Neurology"},{"key":"10.1016\/j.jpsychires.2026.01.050_bib158","first-page":"192","article-title":"A randomized, double-blind, phase 2 study of the effects of the vaccine vanutide cridificar with QS-21 adjuvant on immunogenicity, safety and amyloid imaging in patients with mild to moderate Alzheimer's disease","volume":"3","author":"Ketter","year":"2016","journal-title":"J. Prev. Alzheimers Dis."},{"key":"10.1016\/j.jpsychires.2026.01.050_bib159","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1038\/nn.3318","article-title":"Microglia emerge from erythromyeloid precursors via Pu.1- and Irf8-dependent pathways","volume":"16","author":"Kierdorf","year":"2013","journal-title":"Nat. Neurosci."},{"key":"10.1016\/j.jpsychires.2026.01.050_bib160","doi-asserted-by":"crossref","first-page":"2185","DOI":"10.1038\/s41467-021-22479-4","article-title":"Therapeutic B-cell depletion reverses progression of Alzheimer's disease","volume":"12","author":"Kim","year":"2021","journal-title":"Nat. Commun."},{"key":"10.1016\/j.jpsychires.2026.01.050_bib161","doi-asserted-by":"crossref","first-page":"83","DOI":"10.3233\/JAD-215699","article-title":"Alzheimer's disease: key insights from two decades of clinical trial failures","volume":"87","author":"Kim","year":"2022","journal-title":"J. Alzheimers Dis."},{"key":"10.1016\/j.jpsychires.2026.01.050_bib162","doi-asserted-by":"crossref","DOI":"10.1002\/cbic.202300328","article-title":"Failure, success, and future direction of alzheimer drugs targeting amyloid-beta Cascade: pros and cons of chemical and biological modalities","volume":"24","author":"Kim","year":"2023","journal-title":"Chembiochem"},{"key":"10.1016\/j.jpsychires.2026.01.050_bib163","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1038\/s12276-023-01148-0","article-title":"Pathological phenotypes of astrocytes in Alzheimer's disease","volume":"56","author":"Kim","year":"2024","journal-title":"Exp. Mol. Med."},{"key":"10.1016\/j.jpsychires.2026.01.050_bib164","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1186\/s13024-024-00740-w","article-title":"Astrocytic autophagy plasticity modulates Abeta clearance and cognitive function in Alzheimer's disease","volume":"19","author":"Kim","year":"2024","journal-title":"Mol. Neurodegener."},{"key":"10.1016\/j.jpsychires.2026.01.050_bib165","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1016\/j.trci.2018.06.014","article-title":"Inflammation as a central mechanism in Alzheimer's disease","volume":"4","author":"Kinney","year":"2018","journal-title":"Alzheimer's Dement."},{"key":"10.1016\/j.jpsychires.2026.01.050_bib166","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1196\/annals.1332.006","article-title":"Microglia as a potential bridge between the amyloid beta-peptide and tau","volume":"1035","author":"Kitazawa","year":"2004","journal-title":"Ann. N. Y. Acad. Sci."},{"key":"10.1016\/j.jpsychires.2026.01.050_bib167","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1038\/nm1058","article-title":"Apolipoprotein E promotes astrocyte colocalization and degradation of deposited amyloid-beta peptides","volume":"10","author":"Koistinaho","year":"2004","journal-title":"Nat. Med."},{"key":"10.1016\/j.jpsychires.2026.01.050_bib168","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1186\/s40035-022-00333-x","article-title":"Enhanced delivery of a low dose of aducanumab via FUS in 5xFAD mice, an AD model","volume":"11","author":"Kong","year":"2022","journal-title":"Transl. Neurodegener."},{"key":"10.1016\/j.jpsychires.2026.01.050_bib169","doi-asserted-by":"crossref","first-page":"413","DOI":"10.3389\/fnagi.2018.00413","article-title":"Editorial: neuroinflammation and cognition","volume":"10","author":"Kumar","year":"2018","journal-title":"Front. Aging Neurosci."},{"key":"10.1016\/j.jpsychires.2026.01.050_bib170","series-title":"StatPearls [Internet]","author":"Kumar","year":"2025"},{"key":"10.1016\/j.jpsychires.2026.01.050_bib171","doi-asserted-by":"crossref","DOI":"10.3389\/fneur.2024.1398089","article-title":"Neural regeneration in the human central nervous system-from understanding the underlying mechanisms to developing treatments. Where do we stand today?","volume":"15","author":"Kvistad","year":"2024","journal-title":"Front. Neurol."},{"key":"10.1016\/j.jpsychires.2026.01.050_bib172","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1186\/s40035-020-00221-2","article-title":"Neuroinflammation in neurodegenerative disorders: the roles of microglia and astrocytes","volume":"9","author":"Kwon","year":"2020","journal-title":"Transl. Neurodegener."},{"key":"10.1016\/j.jpsychires.2026.01.050_bib173","doi-asserted-by":"crossref","first-page":"1478","DOI":"10.1002\/glia.23974","article-title":"Expression and secretion of apoE isoforms in astrocytes and microglia during inflammation","volume":"69","author":"Lanfranco","year":"2021","journal-title":"Glia"},{"key":"10.1016\/j.jpsychires.2026.01.050_bib174","doi-asserted-by":"crossref","first-page":"2327","DOI":"10.1002\/alz.12610","article-title":"Role of chronic neuroinflammation in neuroplasticity and cognitive function: a hypothesis","volume":"18","author":"Lecca","year":"2022","journal-title":"Alzheimer's Dement."},{"key":"10.1016\/j.jpsychires.2026.01.050_bib175","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1038\/s41582-020-00435-y","article-title":"Neuroinflammation and microglial activation in Alzheimer disease: where do we go from here?","volume":"17","author":"Leng","year":"2021","journal-title":"Nat. Rev. Neurol."},{"key":"10.1016\/j.jpsychires.2026.01.050_bib176","doi-asserted-by":"crossref","DOI":"10.15252\/emmm.201809027","article-title":"High-affinity interactions and signal transduction between Abeta oligomers and TREM2","volume":"10","author":"Lessard","year":"2018","journal-title":"EMBO Mol. Med."},{"key":"10.1016\/j.jpsychires.2026.01.050_bib177","doi-asserted-by":"crossref","first-page":"1217","DOI":"10.1038\/s41593-019-0433-0","article-title":"TREM2 function impedes tau seeding in neuritic plaques","volume":"22","author":"Leyns","year":"2019","journal-title":"Nat. Neurosci."},{"key":"10.1016\/j.jpsychires.2026.01.050_bib178","doi-asserted-by":"crossref","DOI":"10.3389\/fnagi.2022.937486","article-title":"Global, regional, and national burden of Alzheimer's disease and other dementias, 1990-2019","volume":"14","author":"Li","year":"2022","journal-title":"Front. Aging Neurosci."},{"key":"10.1016\/j.jpsychires.2026.01.050_bib179","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/j.neuron.2014.11.018","article-title":"NFkappaB-activated astroglial release of complement C3 compromises neuronal morphology and function associated with Alzheimer's disease","volume":"85","author":"Lian","year":"2015","journal-title":"Neuron"},{"key":"10.1016\/j.jpsychires.2026.01.050_bib180","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1523\/JNEUROSCI.2117-15.2016","article-title":"Astrocyte-Microglia cross talk through complement activation modulates amyloid pathology in mouse models of Alzheimer's Disease","volume":"36","author":"Lian","year":"2016","journal-title":"J. Neurosci."},{"key":"10.1016\/j.jpsychires.2026.01.050_bib181","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1038\/nature21029","article-title":"Neurotoxic reactive astrocytes are induced by activated microglia","volume":"541","author":"Liddelow","year":"2017","journal-title":"Nature"},{"key":"10.1016\/j.jpsychires.2026.01.050_bib182","doi-asserted-by":"crossref","first-page":"229","DOI":"10.3389\/fncel.2014.00229","article-title":"Modulating neurotoxicity through CX3CL1\/CX3CR1 signaling","volume":"8","author":"Limatola","year":"2014","journal-title":"Front. Cell. Neurosci."},{"key":"10.1016\/j.jpsychires.2026.01.050_bib183","doi-asserted-by":"crossref","first-page":"21","DOI":"10.4161\/pri.1.1.4055","article-title":"Tau aggregation in Alzheimer's disease: what role for phosphorylation?","volume":"1","author":"Lippens","year":"2007","journal-title":"Prion"},{"key":"10.1016\/j.jpsychires.2026.01.050_bib184","doi-asserted-by":"crossref","first-page":"953","DOI":"10.1016\/j.clinthera.2021.05.006","article-title":"Modifiable risk factors in alzheimer disease and related dementias: a review","volume":"43","author":"Litke","year":"2021","journal-title":"Clin. Ther."},{"key":"10.1016\/j.jpsychires.2026.01.050_bib185","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1007\/s12264-013-1410-3","article-title":"Lipid metabolism in Alzheimer's disease","volume":"30","author":"Liu","year":"2014","journal-title":"Neurosci. Bull."},{"key":"10.1016\/j.jpsychires.2026.01.050_bib186","doi-asserted-by":"crossref","first-page":"1098","DOI":"10.4049\/jimmunol.1101121","article-title":"TLR2 is a primary receptor for Alzheimer's amyloid beta peptide to trigger neuroinflammatory activation","volume":"188","author":"Liu","year":"2012","journal-title":"J. Immunol."},{"key":"10.1016\/j.jpsychires.2026.01.050_bib187","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1038\/nrneurol.2012.263","article-title":"Apolipoprotein E and Alzheimer disease: risk, mechanisms and therapy","volume":"9","author":"Liu","year":"2013","journal-title":"Nat. Rev. Neurol."},{"key":"10.1016\/j.jpsychires.2026.01.050_bib188","doi-asserted-by":"crossref","first-page":"1144","DOI":"10.1016\/j.bbrc.2017.11.122","article-title":"Cerebrospinal fluid CD4+ T lymphocyte-derived miRNA-let-7b can enhances the diagnostic performance of Alzheimer's disease biomarkers","volume":"495","author":"Liu","year":"2018","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.jpsychires.2026.01.050_bib189","doi-asserted-by":"crossref","first-page":"1854","DOI":"10.1038\/s41590-023-01640-9","article-title":"Cell-autonomous effects of APOE4 in restricting microglial response in brain homeostasis and Alzheimer's disease","volume":"24","author":"Liu","year":"2023","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.jpsychires.2026.01.050_bib190","doi-asserted-by":"crossref","first-page":"321","DOI":"10.3233\/ADR-210296","article-title":"Phase II (NAVIGATE-AD study) results of LY3202626 effects on patients with mild Alzheimer's Disease dementia","volume":"5","author":"Lo","year":"2021","journal-title":"J. Alzheimers Dis. Rep."},{"key":"10.1016\/j.jpsychires.2026.01.050_bib191","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1038\/nm0502-500","article-title":"Gene-microarray analysis of multiple sclerosis lesions yields new targets validated in autoimmune encephalomyelitis","volume":"8","author":"Lock","year":"2002","journal-title":"Nat. Med."},{"key":"10.1016\/j.jpsychires.2026.01.050_bib192","doi-asserted-by":"crossref","first-page":"1735","DOI":"10.1002\/alz.12341","article-title":"Acute systemic inflammation exacerbates neuroinflammation in Alzheimer's disease: IL-1beta drives amplified responses in primed astrocytes and neuronal network dysfunction","volume":"17","author":"Lopez-Rodriguez","year":"2021","journal-title":"Alzheimer's Dement."},{"key":"10.1016\/j.jpsychires.2026.01.050_bib193","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/j.neurobiolaging.2014.08.008","article-title":"Clinical relevance of specific T-cell activation in the blood and cerebrospinal fluid of patients with mild Alzheimer's disease","volume":"36","author":"Lueg","year":"2015","journal-title":"Neurobiol. Aging"},{"key":"10.1016\/j.jpsychires.2026.01.050_bib194","doi-asserted-by":"crossref","DOI":"10.4155\/fso.15.9","article-title":"The role and therapeutic targeting of alpha-, beta- and gamma-secretase in Alzheimer's disease","volume":"1","author":"MacLeod","year":"2015","journal-title":"Future Sci. OA"},{"key":"10.1016\/j.jpsychires.2026.01.050_bib195","doi-asserted-by":"crossref","DOI":"10.3390\/cells8121477","article-title":"The brain entangled: the contribution of neutrophil extracellular traps to the diseases of the central nervous System","volume":"8","author":"Manda-Handzlik","year":"2019","journal-title":"Cells"},{"key":"10.1016\/j.jpsychires.2026.01.050_bib196","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1038\/ncpneuro0355","article-title":"Mechanisms of Disease: astrocytes in neurodegenerative disease","volume":"2","author":"Maragakis","year":"2006","journal-title":"Nat. Clin. Pract. Neurol."},{"key":"10.1016\/j.jpsychires.2026.01.050_bib197","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1186\/s13223-018-0278-1","article-title":"An introduction to immunology and immunopathology","volume":"14","author":"Marshall","year":"2018","journal-title":"Allergy Asthma Clin. Immunol."},{"key":"10.1016\/j.jpsychires.2026.01.050_bib198","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1016\/S0306-4522(01)00289-5","article-title":"Altered expression of apolipoprotein E, amyloid precursor protein and presenilin-1 is associated with chronic reactive gliosis in rat cortical tissue","volume":"106","author":"Martins","year":"2001","journal-title":"Neuroscience"},{"key":"10.1016\/j.jpsychires.2026.01.050_bib199","doi-asserted-by":"crossref","DOI":"10.1038\/nrdp.2015.56","article-title":"Alzheimer's disease","volume":"1","author":"Masters","year":"2015","journal-title":"Nat. Rev. Dis. Primers"},{"key":"10.1016\/j.jpsychires.2026.01.050_bib200","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1007\/s00401-013-1177-7","article-title":"The amyloid cascade-inflammatory hypothesis of Alzheimer disease: implications for therapy","volume":"126","author":"McGeer","year":"2013","journal-title":"Acta Neuropathol."},{"key":"10.1016\/j.jpsychires.2026.01.050_bib201","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/0304-3940(87)90696-3","article-title":"Reactive microglia in patients with senile dementia of the Alzheimer type are positive for the histocompatibility glycoprotein HLA-DR","volume":"79","author":"McGeer","year":"1987","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.jpsychires.2026.01.050_bib202","doi-asserted-by":"crossref","first-page":"1285","DOI":"10.1212\/WNL.38.8.1285","article-title":"Reactive microglia are positive for HLA-DR in the substantia nigra of Parkinson's and Alzheimer's disease brains","volume":"38","author":"McGeer","year":"1988","journal-title":"Neurology"},{"key":"10.1016\/j.jpsychires.2026.01.050_bib203","article-title":"A clinical trial for the assessment of lenalidomide in amnestic MCI patients (MCLENA-1)","year":"2025","journal-title":"ClinicalTrialsgov"},{"key":"10.1016\/j.jpsychires.2026.01.050_bib204","doi-asserted-by":"crossref","first-page":"5370","DOI":"10.1038\/s41467-020-19227-5","article-title":"Gene expression and functional deficits underlie TREM2-knockout microglia responses in human models of Alzheimer's disease","volume":"11","author":"McQuade","year":"2020","journal-title":"Nat. Commun."},{"key":"10.1016\/j.jpsychires.2026.01.050_bib205","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1080\/13543784.2017.1323868","article-title":"Why do trials for Alzheimer's disease drugs keep failing? A discontinued drug perspective for 2010-2015","volume":"26","author":"Mehta","year":"2017","journal-title":"Expet Opin. Invest. Drugs"},{"key":"10.1016\/j.jpsychires.2026.01.050_bib206","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1159\/000486200","article-title":"Extravascular CD3+ T cells in brains of alzheimer disease patients correlate with Tau but not with amyloid pathology: an immunohistochemical Study","volume":"18","author":"Merlini","year":"2018","journal-title":"Neurodegener. Dis."},{"key":"10.1016\/j.jpsychires.2026.01.050_bib207","doi-asserted-by":"crossref","first-page":"2487","DOI":"10.1093\/brain\/awp144","article-title":"CCR2+Ly-6Chi monocytes are crucial for the effector phase of autoimmunity in the central nervous system","volume":"132","author":"Mildner","year":"2009","journal-title":"Brain"},{"key":"10.1016\/j.jpsychires.2026.01.050_bib208","doi-asserted-by":"crossref","first-page":"10273","DOI":"10.1073\/pnas.191118298","article-title":"Immune hyporesponsiveness to amyloid beta-peptide in amyloid precursor protein transgenic mice: implications for the pathogenesis and treatment of Alzheimer's disease","volume":"98","author":"Monsonego","year":"2001","journal-title":"Proc. Natl. Acad. Sci. U. S. A"},{"key":"10.1016\/j.jpsychires.2026.01.050_bib209","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1172\/JCI200318104","article-title":"Increased T cell reactivity to amyloid beta protein in older humans and patients with Alzheimer disease","volume":"112","author":"Monsonego","year":"2003","journal-title":"J. Clin. Investig."},{"key":"10.1016\/j.jpsychires.2026.01.050_bib210","doi-asserted-by":"crossref","DOI":"10.1016\/j.drudis.2023.103487","article-title":"Hyperphosphorylated tau (p-tau) and drug discovery in the context of Alzheimer's disease and related tauopathies","volume":"28","author":"Moore","year":"2023","journal-title":"Drug Discov. Today"},{"key":"10.1016\/j.jpsychires.2026.01.050_bib211","doi-asserted-by":"crossref","first-page":"211","DOI":"10.2147\/nedt.2007.3.2.211","article-title":"Rivastigmine in the treatment of patients with Alzheimer's disease","volume":"3","author":"Muller","year":"2007","journal-title":"Neuropsychiatric Dis. Treat."},{"key":"10.1016\/j.jpsychires.2026.01.050_bib212","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1007\/s12640-011-9306-3","article-title":"Abeta potentiates inflammatory activation of glial cells induced by scavenger receptor ligands and inflammatory mediators in culture","volume":"22","author":"Murgas","year":"2012","journal-title":"Neurotox. Res."},{"key":"10.1016\/j.jpsychires.2026.01.050_bib213","doi-asserted-by":"crossref","first-page":"311","DOI":"10.3233\/JAD-2010-1221","article-title":"Alzheimer's disease and the amyloid-beta peptide","volume":"19","author":"Murphy","year":"2010","journal-title":"J. Alzheimers Dis."},{"key":"10.1016\/j.jpsychires.2026.01.050_bib214","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/S0006-8993(03)02361-8","article-title":"Astrocytes accumulate A beta 42 and give rise to astrocytic amyloid plaques in Alzheimer disease brains","volume":"971","author":"Nagele","year":"2003","journal-title":"Brain Res."},{"key":"10.1016\/j.jpsychires.2026.01.050_bib215","doi-asserted-by":"crossref","first-page":"1","DOI":"10.33160\/yam.2024.02.001","article-title":"Roles of microglia in neurodegenerative diseases","volume":"67","author":"Nakaso","year":"2024","journal-title":"Yonago Acta Med."},{"key":"10.1016\/j.jpsychires.2026.01.050_bib216","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2020.107975","article-title":"Excessive astrocytic GABA causes cortical hypometabolism and impedes functional recovery after subcortical stroke","volume":"32","author":"Nam","year":"2020","journal-title":"Cell Rep."},{"key":"10.1016\/j.jpsychires.2026.01.050_bib217","doi-asserted-by":"crossref","DOI":"10.3390\/ijms23084453","article-title":"Revisiting the role of astrocytic MAOB in Parkinson's Disease","volume":"23","author":"Nam","year":"2022","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.jpsychires.2026.01.050_bib218","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1186\/s40478-018-0515-3","article-title":"White matter changes in Alzheimer's disease: a focus on myelin and oligodendrocytes","volume":"6","author":"Nasrabady","year":"2018","journal-title":"Acta Neuropathol. Commun."},{"key":"10.1016\/j.jpsychires.2026.01.050_bib219","unstructured":"National Institutes of Health, National library of medicine, and national center for biotechnology information. Alzheimer's disease | Completed, Terminated Studies. ClinicalTrialsgov."},{"key":"10.1016\/j.jpsychires.2026.01.050_bib220","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1016\/S1471-4914(03)00109-6","article-title":"A new role for astrocytes: beta-amyloid homeostasis and degradation","volume":"9","author":"Nicoll","year":"2003","journal-title":"Trends Mol. Med."},{"key":"10.1016\/j.jpsychires.2026.01.050_bib221","series-title":"2025 NIH Alzheimer's Disease and Related Dementias Research Progress Report: Advances and Achievements","year":"2025"},{"key":"10.1016\/j.jpsychires.2026.01.050_bib222","doi-asserted-by":"crossref","first-page":"1314","DOI":"10.1126\/science.1110647","article-title":"Resting microglial cells are highly dynamic surveillants of brain parenchyma in vivo","volume":"308","author":"Nimmerjahn","year":"2005","journal-title":"Science"},{"key":"10.1016\/j.jpsychires.2026.01.050_bib223","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1007\/978-981-13-3540-2_2","article-title":"Epidemiological evidence of the relationship between diabetes and dementia","volume":"1128","author":"Ninomiya","year":"2019","journal-title":"Adv. Exp. Med. Biol."},{"key":"10.1016\/j.jpsychires.2026.01.050_bib224","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1007\/s12035-013-8483-x","article-title":"The role of inflammatory and oxidative stress mechanisms in the pathogenesis of Parkinson's disease: focus on astrocytes","volume":"49","author":"Niranjan","year":"2014","journal-title":"Mol. Neurobiol."},{"key":"10.1016\/j.jpsychires.2026.01.050_bib225","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1111\/j.1365-2990.2012.01306.x","article-title":"Review: microglia of the aged brain: primed to be activated and resistant to regulation","volume":"39","author":"Norden","year":"2013","journal-title":"Neuropathol. Appl. Neurobiol."},{"key":"10.1016\/j.jpsychires.2026.01.050_bib226","doi-asserted-by":"crossref","DOI":"10.3389\/fnmol.2023.1279740","article-title":"Gamma-secretase modulators: a promising route for the treatment of Alzheimer's disease","volume":"16","author":"Nordvall","year":"2023","journal-title":"Front. Mol. Neurosci."},{"key":"10.1016\/j.jpsychires.2026.01.050_bib227","first-page":"1387","article-title":"[Depression and dementia: perspectives from clinical studies]","volume":"64","author":"Nozaki","year":"2012","journal-title":"Brain Nerve"},{"key":"10.1016\/j.jpsychires.2026.01.050_bib228","doi-asserted-by":"crossref","DOI":"10.1155\/2020\/2638130","article-title":"RNA and oxidative stress in Alzheimer's disease: focus on microRNAs","volume":"2020","author":"Nunomura","year":"2020","journal-title":"Oxid. Med. Cell. Longev."},{"key":"10.1016\/j.jpsychires.2026.01.050_bib229","doi-asserted-by":"crossref","DOI":"10.3390\/ijms19061743","article-title":"Molecular mechanisms of oligodendrocyte regeneration in white matter-related diseases","volume":"19","author":"Ohtomo","year":"2018","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.jpsychires.2026.01.050_bib230","doi-asserted-by":"crossref","first-page":"831","DOI":"10.1002\/glia.20967","article-title":"Concomitant astroglial atrophy and astrogliosis in a triple transgenic animal model of Alzheimer's disease","volume":"58","author":"Olabarria","year":"2010","journal-title":"Glia"},{"key":"10.1016\/j.jpsychires.2026.01.050_bib231","doi-asserted-by":"crossref","first-page":"891","DOI":"10.1093\/brain\/awv379","article-title":"Pharmacological targeting of CSF1R inhibits microglial proliferation and prevents the progression of alzheimer's-like pathology","volume":"139","author":"Olmos-Alonso","year":"2016","journal-title":"Brain"},{"key":"10.1016\/j.jpsychires.2026.01.050_bib232","doi-asserted-by":"crossref","first-page":"1096","DOI":"10.1038\/nn.3161","article-title":"Immune surveillance in the central nervous system","volume":"15","author":"Ousman","year":"2012","journal-title":"Nat. Neurosci."},{"key":"10.1016\/j.jpsychires.2026.01.050_bib233","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1002\/glia.22608","article-title":"Interferons in the central nervous system: a few instruments play many tunes","volume":"62","author":"Owens","year":"2014","journal-title":"Glia"},{"key":"10.1016\/j.jpsychires.2026.01.050_bib234","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1385\/NMM:3:1:53","article-title":"Presenilin-1 mutation sensitizes oligodendrocytes to glutamate and amyloid toxicities, and exacerbates white matter damage and memory impairment in mice","volume":"3","author":"Pak","year":"2003","journal-title":"NeuroMolecular Med."},{"key":"10.1016\/j.jpsychires.2026.01.050_bib235","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/j.tips.2010.12.007","article-title":"Neuroprotective therapeutics for Alzheimer's disease: progress and prospects","volume":"32","author":"Palmer","year":"2011","journal-title":"Trends Pharmacol. Sci."},{"key":"10.1016\/j.jpsychires.2026.01.050_bib236","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1080\/14737175.2019.1621751","article-title":"Do BACE inhibitor failures in Alzheimer patients challenge the amyloid hypothesis of the disease?","volume":"19","author":"Panza","year":"2019","journal-title":"Expert Rev. Neurother."},{"key":"10.1016\/j.jpsychires.2026.01.050_bib237","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1038\/s41582-018-0116-6","article-title":"A critical appraisal of amyloid-beta-targeting therapies for Alzheimer disease","volume":"15","author":"Panza","year":"2019","journal-title":"Nat. Rev. Neurol."},{"key":"10.1016\/j.jpsychires.2026.01.050_bib238","doi-asserted-by":"crossref","first-page":"1456","DOI":"10.1126\/science.1202529","article-title":"Synaptic pruning by microglia is necessary for normal brain development","volume":"333","author":"Paolicelli","year":"2011","journal-title":"Science"},{"key":"10.1016\/j.jpsychires.2026.01.050_bib239","doi-asserted-by":"crossref","first-page":"1821","DOI":"10.1016\/j.neurobiolaging.2006.08.014","article-title":"Inflammatory changes parallel the early stages of Alzheimer disease","volume":"28","author":"Parachikova","year":"2007","journal-title":"Neurobiol. Aging"},{"key":"10.1016\/j.jpsychires.2026.01.050_bib240","doi-asserted-by":"crossref","DOI":"10.1016\/j.conb.2023.102732","article-title":"Astrocyte-dependent circuit remodeling by synapse phagocytosis","volume":"81","author":"Park","year":"2023","journal-title":"Curr. Opin. Neurobiol."},{"key":"10.1016\/j.jpsychires.2026.01.050_bib241","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1007\/s11910-015-0531-7","article-title":"The role of neuroinflammation in dementias","volume":"15","author":"Pasqualetti","year":"2015","journal-title":"Curr. Neurol. Neurosci. Rep."},{"key":"10.1016\/j.jpsychires.2026.01.050_bib242","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1111\/imm.12163","article-title":"Oligodendrocyte-microglia cross-talk in the central nervous system","volume":"141","author":"Peferoen","year":"2014","journal-title":"Immunology"},{"key":"10.1016\/j.jpsychires.2026.01.050_bib243","doi-asserted-by":"crossref","DOI":"10.3390\/nu16244368","article-title":"Mechanisms and potential benefits of neuroprotective agents in neurological health","volume":"16","author":"Pekdemir","year":"2024","journal-title":"Nutrients"},{"key":"10.1016\/j.jpsychires.2026.01.050_bib244","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1016\/j.neulet.2013.12.071","article-title":"The dual role of astrocyte activation and reactive gliosis","volume":"565","author":"Pekny","year":"2014","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.jpsychires.2026.01.050_bib245","doi-asserted-by":"crossref","first-page":"114","DOI":"10.3389\/fnagi.2018.00114","article-title":"Deciphering the Astrocyte reaction in Alzheimer's disease","volume":"10","author":"Perez-Nievas","year":"2018","journal-title":"Front. Aging Neurosci."},{"key":"10.1016\/j.jpsychires.2026.01.050_bib246","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1016\/S1357-4310(97)01077-0","article-title":"The blood-brain barrier and the inflammatory response","volume":"3","author":"Perry","year":"1997","journal-title":"Mol. Med. Today"},{"key":"10.1016\/j.jpsychires.2026.01.050_bib247","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1038\/nrneurol.2010.17","article-title":"Microglia in neurodegenerative disease","volume":"6","author":"Perry","year":"2010","journal-title":"Nat. Rev. Neurol."},{"key":"10.1016\/j.jpsychires.2026.01.050_bib248","doi-asserted-by":"crossref","first-page":"211","DOI":"10.3389\/fimmu.2017.00211","article-title":"NETosis in Alzheimer's disease","volume":"8","author":"Pietronigro","year":"2017","journal-title":"Front. Immunol."},{"key":"10.1016\/j.jpsychires.2026.01.050_bib249","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1002\/jnr.23827","article-title":"Sex and the development of Alzheimer's disease","volume":"95","author":"Pike","year":"2017","journal-title":"J. Neurosci. Res."},{"key":"10.1016\/j.jpsychires.2026.01.050_bib250","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1186\/s12974-020-01915-0","article-title":"Therapeutic Trem2 activation ameliorates amyloid-beta deposition and improves cognition in the 5XFAD model of amyloid deposition","volume":"17","author":"Price","year":"2020","journal-title":"J. Neuroinflammation"},{"key":"10.1016\/j.jpsychires.2026.01.050_bib251","doi-asserted-by":"crossref","first-page":"1356","DOI":"10.1038\/nm1201-1356","article-title":"Targeting gene-modified hematopoietic cells to the central nervous system: use of green fluorescent protein uncovers microglial engraftment","volume":"7","author":"Priller","year":"2001","journal-title":"Nat. Med."},{"key":"10.1016\/j.jpsychires.2026.01.050_bib252","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1007\/978-1-61779-452-0_16","article-title":"ELISA methodology to quantify astrocyte production of cytokines\/chemokines in vitro","volume":"814","author":"Qin","year":"2012","journal-title":"Methods Mol. Biol."},{"key":"10.1016\/j.jpsychires.2026.01.050_bib253","doi-asserted-by":"crossref","first-page":"1884","DOI":"10.3389\/fimmu.2020.01884","article-title":"Regulatory B cells and its role in central nervous system inflammatory demyelinating diseases","volume":"11","author":"Ran","year":"2020","journal-title":"Front. Immunol."},{"key":"10.1016\/j.jpsychires.2026.01.050_bib254","article-title":"Donanemab for Alzheimer's disease: a systematic review of clinical trials","volume":"11","author":"Rashad","year":"2022","journal-title":"Healthcare (Basel)"},{"key":"10.1016\/j.jpsychires.2026.01.050_bib255","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1186\/s13024-022-00574-4","article-title":"ApoE in Alzheimer's disease: pathophysiology and therapeutic strategies","volume":"17","author":"Raulin","year":"2022","journal-title":"Mol. Neurodegener."},{"key":"10.1016\/j.jpsychires.2026.01.050_bib256","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1586\/14737175.8.1.9","article-title":"Galantamine in Alzheimer's disease","volume":"8","author":"Razay","year":"2008","journal-title":"Expert Rev. Neurother."},{"key":"10.1016\/j.jpsychires.2026.01.050_bib257","doi-asserted-by":"crossref","first-page":"160","DOI":"10.3389\/fnagi.2016.00160","article-title":"Mechanisms of abeta clearance and degradation by glial cells","volume":"8","author":"Ries","year":"2016","journal-title":"Front. Aging Neurosci."},{"key":"10.1016\/j.jpsychires.2026.01.050_bib258","doi-asserted-by":"crossref","first-page":"1839","DOI":"10.1002\/alz.13532","article-title":"Effects of the active amyloid beta immunotherapy CAD106 on PET measurements of amyloid plaque deposition in cognitively unimpaired APOE epsilon4 homozygotes","volume":"20","author":"Riviere","year":"2024","journal-title":"Alzheimer's Dement."},{"key":"10.1016\/j.jpsychires.2026.01.050_bib259","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1002\/jnr.1095","article-title":"Neuronal and glial beta-secretase (BACE) protein expression in transgenic Tg2576 mice with amyloid plaque pathology","volume":"64","author":"Rossner","year":"2001","journal-title":"J. Neurosci. Res."},{"key":"10.1016\/j.jpsychires.2026.01.050_bib260","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1111\/j.1471-4159.2004.02857.x","article-title":"Alzheimer's disease beta-secretase BACE1 is not a neuron-specific enzyme","volume":"92","author":"Rossner","year":"2005","journal-title":"J. Neurochem."},{"key":"10.1016\/j.jpsychires.2026.01.050_bib261","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1007\/s00281-015-0515-3","article-title":"Control of autoimmune CNS inflammation by astrocytes","volume":"37","author":"Rothhammer","year":"2015","journal-title":"Semin. Immunopathol."},{"key":"10.1016\/j.jpsychires.2026.01.050_bib262","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1159\/000369101","article-title":"Amyloid-beta: a crucial factor in Alzheimer's disease","volume":"24","author":"Sadigh-Eteghad","year":"2015","journal-title":"Med. Princ. Pract."},{"key":"10.1016\/j.jpsychires.2026.01.050_bib263","doi-asserted-by":"crossref","first-page":"1018","DOI":"10.1038\/nm.4397","article-title":"Microglia emerge as central players in brain disease","volume":"23","author":"Salter","year":"2017","journal-title":"Nat. Med."},{"key":"10.1016\/j.jpsychires.2026.01.050_bib264","doi-asserted-by":"crossref","first-page":"549","DOI":"10.4103\/1673-5374.205084","article-title":"Neurotrophic factors in Alzheimer's and Parkinson's diseases: implications for pathogenesis and therapy","volume":"12","author":"Sampaio","year":"2017","journal-title":"Neural Regen. Res."},{"key":"10.1016\/j.jpsychires.2026.01.050_bib265","doi-asserted-by":"crossref","DOI":"10.3390\/ijms21093343","article-title":"A synergistic effect of reactive oxygen and reactive nitrogen species in Plasma activated liquid media triggers Astrocyte wound healing","volume":"21","author":"Sardella","year":"2020","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.jpsychires.2026.01.050_bib266","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1016\/j.bbi.2010.12.004","article-title":"Increased activity of Th-17 and Th-9 lymphocytes and a skewing of the post-thymic differentiation pathway are seen in Alzheimer's disease","volume":"25","author":"Saresella","year":"2011","journal-title":"Brain Behav. Immun."},{"key":"10.1016\/j.jpsychires.2026.01.050_bib267","doi-asserted-by":"crossref","first-page":"1668","DOI":"10.1038\/s41593-024-01730-3","article-title":"Oligodendrocytes produce amyloid-beta and contribute to plaque formation alongside neurons in Alzheimer's disease model mice","volume":"27","author":"Sasmita","year":"2024","journal-title":"Nat. Neurosci."},{"key":"10.1016\/j.jpsychires.2026.01.050_bib268","doi-asserted-by":"crossref","first-page":"1905","DOI":"10.3389\/fimmu.2017.01905","article-title":"Neuroinflammation: microglia and T cells get ready to tango","volume":"8","author":"Schetters","year":"2017","journal-title":"Front. Immunol."},{"key":"10.1016\/j.jpsychires.2026.01.050_bib269","doi-asserted-by":"crossref","DOI":"10.15252\/emmm.201911227","article-title":"Enhancing protective microglial activities with a dual function TREM2 antibody to the stalk region","volume":"12","author":"Schlepckow","year":"2020","journal-title":"EMBO Mol. Med."},{"key":"10.1016\/j.jpsychires.2026.01.050_bib270","doi-asserted-by":"crossref","first-page":"1119","DOI":"10.1100\/tsw.2008.140","article-title":"Cytokines and myelination in the central nervous system","volume":"8","author":"Schmitz","year":"2008","journal-title":"Sci. World J."},{"key":"10.1016\/j.jpsychires.2026.01.050_bib271","doi-asserted-by":"crossref","first-page":"2197","DOI":"10.1212\/01.wnl.0000271090.28148.24","article-title":"Mixed brain pathologies account for most dementia cases in community-dwelling older persons","volume":"69","author":"Schneider","year":"2007","journal-title":"Neurology"},{"key":"10.1016\/j.jpsychires.2026.01.050_bib272","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1002\/ana.21706","article-title":"The neuropathology of probable Alzheimer disease and mild cognitive impairment","volume":"66","author":"Schneider","year":"2009","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.jpsychires.2026.01.050_bib273","doi-asserted-by":"crossref","first-page":"2187","DOI":"10.1038\/s41591-023-02505-2","article-title":"Emerging diagnostics and therapeutics for Alzheimer disease","volume":"29","author":"Self","year":"2023","journal-title":"Nat. Med."},{"key":"10.1016\/j.jpsychires.2026.01.050_bib274","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1152\/physrev.2001.81.2.741","article-title":"Alzheimer's disease: genes, proteins, and therapy","volume":"81","author":"Selkoe","year":"2001","journal-title":"Physiol. Rev."},{"key":"10.1016\/j.jpsychires.2026.01.050_bib275","doi-asserted-by":"crossref","first-page":"595","DOI":"10.15252\/emmm.201606210","article-title":"The amyloid hypothesis of Alzheimer's disease at 25 years","volume":"8","author":"Selkoe","year":"2016","journal-title":"EMBO Mol. Med."},{"key":"10.1016\/j.jpsychires.2026.01.050_bib276","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1016\/S1474-4422(20)30412-9","article-title":"APOE and Alzheimer's disease: advances in genetics, pathophysiology, and therapeutic approaches","volume":"20","author":"Serrano-Pozo","year":"2021","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.jpsychires.2026.01.050_bib277","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1038\/nature24016","article-title":"ApoE4 markedly exacerbates tau-mediated neurodegeneration in a mouse model of tauopathy","volume":"549","author":"Shi","year":"2017","journal-title":"Nature"},{"key":"10.1016\/j.jpsychires.2026.01.050_bib278","doi-asserted-by":"crossref","first-page":"5294","DOI":"10.1523\/JNEUROSCI.2427-21.2022","article-title":"Microglial mTOR activation upregulates Trem2 and enhances beta-amyloid plaque clearance in the 5XFAD Alzheimer's disease model","volume":"42","author":"Shi","year":"2022","journal-title":"J. Neurosci."},{"key":"10.1016\/j.jpsychires.2026.01.050_bib279","doi-asserted-by":"crossref","first-page":"1966","DOI":"10.1007\/s12035-019-01858-5","article-title":"Alzheimer's disease and diabetes: insulin signaling as the Bridge linking two pathologies","volume":"57","author":"Shieh","year":"2020","journal-title":"Mol. Neurobiol."},{"key":"10.1016\/j.jpsychires.2026.01.050_bib280","doi-asserted-by":"crossref","first-page":"6","DOI":"10.3390\/biom6010006","article-title":"Tau protein hyperphosphorylation and aggregation in Alzheimer's disease and other tauopathies, and possible neuroprotective strategies","volume":"6","author":"Simic","year":"2016","journal-title":"Biomolecules"},{"key":"10.1016\/j.jpsychires.2026.01.050_bib281","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1111\/j.1365-2990.2007.00828.x","article-title":"White matter lesions in an unselected cohort of the elderly: astrocytic, microglial and oligodendrocyte precursor cell responses","volume":"33","author":"Simpson","year":"2007","journal-title":"Neuropathol. Appl. Neurobiol."},{"key":"10.1016\/j.jpsychires.2026.01.050_bib282","doi-asserted-by":"crossref","first-page":"542","DOI":"10.30574\/wjarr.2021.12.3.0740","article-title":"Alzheimer's disease and A\u03b2 pathways","volume":"12","author":"Singh","year":"2021","journal-title":"World J. Adv. Res. Rev."},{"key":"10.1016\/j.jpsychires.2026.01.050_bib283","article-title":"Epigenetic regulation of neuroinflammation leading to dementia of alzheimer's disease and other forms of dementias","author":"Singh","year":"2024","journal-title":"Preprintorg"},{"key":"10.1016\/j.jpsychires.2026.01.050_bib284","first-page":"1","article-title":"Epigenetic regulation of neuroinflammation in dementia of alzheimer's disease and other forms of dementias","volume":"8","author":"Singh","year":"2025","journal-title":"EC Clin. Med. Case Rep."},{"key":"10.1016\/j.jpsychires.2026.01.050_bib285","series-title":"Neuroinflammation and Progress in Clinical Trials for the Treatment of Alzheimer's Disease and Related Dementias: an Update","author":"Singh","year":"2025"},{"key":"10.1016\/j.jpsychires.2026.01.050_bib286","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1186\/s41232-023-00277-3","article-title":"Neuroinflammation in Alzheimer's disease: microglial signature and their relevance to disease","volume":"43","author":"Sobue","year":"2023","journal-title":"Inflamm. Regen."},{"key":"10.1016\/j.jpsychires.2026.01.050_bib287","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1177\/1073858413504466","article-title":"Multiple roles for astrocytes as effectors of cytokines and inflammatory mediators","volume":"20","author":"Sofroniew","year":"2014","journal-title":"Neuroscientist"},{"key":"10.1016\/j.jpsychires.2026.01.050_bib288","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1007\/s00401-009-0619-8","article-title":"Astrocytes: biology and pathology","volume":"119","author":"Sofroniew","year":"2010","journal-title":"Acta Neuropathol."},{"key":"10.1016\/j.jpsychires.2026.01.050_bib289","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/j.arr.2016.07.002","article-title":"The endocytic pathway in microglia during health, aging and Alzheimer's disease","volume":"32","author":"Sole-Domenech","year":"2016","journal-title":"Ageing Res. Rev."},{"key":"10.1016\/j.jpsychires.2026.01.050_bib290","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1038\/417039a","article-title":"Astroglia induce neurogenesis from adult neural stem cells","volume":"417","author":"Song","year":"2002","journal-title":"Nature"},{"key":"10.1016\/j.jpsychires.2026.01.050_bib291","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1084\/jem.20171529","article-title":"Humanized TREM2 mice reveal microglia-intrinsic and -extrinsic effects of R47H polymorphism","volume":"215","author":"Song","year":"2018","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.jpsychires.2026.01.050_bib292","doi-asserted-by":"crossref","first-page":"4615","DOI":"10.1007\/s00018-021-03802-0","article-title":"Oxidative stress and impaired oligodendrocyte precursor cell differentiation in neurological disorders","volume":"78","author":"Spaas","year":"2021","journal-title":"Cell. Mol. Life Sci."},{"key":"10.1016\/j.jpsychires.2026.01.050_bib293","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1186\/s40478-015-0251-x","article-title":"Reduced beta-amyloid pathology in an APP transgenic mouse model of Alzheimer's disease lacking functional B and T cells","volume":"3","author":"Spani","year":"2015","journal-title":"Acta Neuropathol. Commun."},{"key":"10.1016\/j.jpsychires.2026.01.050_bib294","doi-asserted-by":"crossref","first-page":"271","DOI":"10.3389\/fnagi.2019.00271","article-title":"Role of microglial cells in Alzheimer's disease tau propagation","volume":"11","author":"Spanic","year":"2019","journal-title":"Front. Aging Neurosci."},{"key":"10.1016\/j.jpsychires.2026.01.050_bib295","doi-asserted-by":"crossref","first-page":"194","DOI":"10.3389\/fnagi.2017.00194","article-title":"Aging microglia-phenotypes, functions and implications for age-related neurodegenerative diseases","volume":"9","author":"Spittau","year":"2017","journal-title":"Front. Aging Neurosci."},{"key":"10.1016\/j.jpsychires.2026.01.050_bib296","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1186\/s12974-017-0910-x","article-title":"Adaptive lymphocyte profiles correlate to brain Abeta burden in patients with mild cognitive impairment","volume":"14","author":"Stowe","year":"2017","journal-title":"J. Neuroinflammation"},{"key":"10.1016\/j.jpsychires.2026.01.050_bib297","doi-asserted-by":"crossref","DOI":"10.3390\/cells12151942","article-title":"Microglia-astrocyte interaction in neural development and neural pathogenesis","volume":"12","author":"Sun","year":"2023","journal-title":"Cells"},{"key":"10.1016\/j.jpsychires.2026.01.050_bib298","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1186\/s13195-021-00813-8","article-title":"A randomized, double-blind, phase 2b proof-of-concept clinical trial in early Alzheimer's disease with lecanemab, an Anti-Abeta protofibril antibody","volume":"13","author":"Swanson","year":"2021","journal-title":"Alzheimers Res. Ther."},{"key":"10.1016\/j.jpsychires.2026.01.050_bib299","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1038\/nrneurol.2017.188","article-title":"Blood-brain barrier breakdown in Alzheimer disease and other neurodegenerative disorders","volume":"14","author":"Sweeney","year":"2018","journal-title":"Nat. Rev. Neurol."},{"key":"10.1016\/j.jpsychires.2026.01.050_bib300","doi-asserted-by":"crossref","DOI":"10.3390\/ijms241511922","article-title":"Emerging roles of cells and molecules of innate immunity in Alzheimer's disease","volume":"24","author":"Tamburini","year":"2023","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.jpsychires.2026.01.050_bib301","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/j.saa.2019.03.004","article-title":"Unravelling the interaction mechanism between clioquinol and bovine serum albumin by multi-spectroscopic and molecular docking approaches","volume":"216","author":"Tantimongcolwat","year":"2019","journal-title":"Spectrochim. Acta Mol. Biomol. Spectrosc."},{"key":"10.1016\/j.jpsychires.2026.01.050_bib302","doi-asserted-by":"crossref","first-page":"1027","DOI":"10.1016\/j.drudis.2022.01.016","article-title":"Challenges and hopes for Alzheimer's disease","volume":"27","author":"Tatulian","year":"2022","journal-title":"Drug Discov. Today"},{"key":"10.1016\/j.jpsychires.2026.01.050_bib303","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/j.smim.2016.04.003","article-title":"Neutrophil-derived chemokines on the road to immunity","volume":"28","author":"Tecchio","year":"2016","journal-title":"Semin. Immunol."},{"key":"10.1016\/j.jpsychires.2026.01.050_bib304","doi-asserted-by":"crossref","first-page":"508","DOI":"10.3389\/fimmu.2014.00508","article-title":"Neutrophil-derived cytokines: facts beyond expression","volume":"5","author":"Tecchio","year":"2014","journal-title":"Front. Immunol."},{"key":"10.1016\/j.jpsychires.2026.01.050_bib305","doi-asserted-by":"crossref","first-page":"8372","DOI":"10.1038\/s41467-025-62405-6","article-title":"CD103(-)CD8(+) T cells promote neurotoxic inflammation in Alzheimer's disease via granzyme K-PAR-1 signaling","volume":"16","author":"Terrabuio","year":"2025","journal-title":"Nat. Commun."},{"key":"10.1016\/j.jpsychires.2026.01.050_bib306","article-title":"Thalidomide for patients with mild to moderate Alzheimer's disease","year":"2012","journal-title":"ClinicalTrialsgov"},{"key":"10.1016\/j.jpsychires.2026.01.050_bib309","unstructured":"Therapeutics: Bapineuzumab. https:\/\/www.alzforum.org\/therapeutics\/bapineuzumab. 2023; Alzeforum networing for cure."},{"key":"10.1016\/j.jpsychires.2026.01.050_bib310","series-title":"ALZFORUM Networing for Cure","year":"2019"},{"key":"10.1016\/j.jpsychires.2026.01.050_bib311","doi-asserted-by":"crossref","first-page":"379","DOI":"10.3233\/JAD-2006-10406","article-title":"An antibody to the beta-secretase cleavage site on amyloid-beta-protein precursor inhibits amyloid-beta production","volume":"10","author":"Thomas","year":"2006","journal-title":"J. Alzheimers Dis."},{"key":"10.1016\/j.jpsychires.2026.01.050_bib312","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1186\/1742-2094-9-155","article-title":"Neuroimmune crosstalk in the central nervous system and its significance for neurological diseases","volume":"9","author":"Tian","year":"2012","journal-title":"J. Neuroinflammation"},{"key":"10.1016\/j.jpsychires.2026.01.050_bib313","doi-asserted-by":"crossref","first-page":"2040","DOI":"10.1038\/s41467-025-57341-4","article-title":"The p3 peptides (Abeta(17-40\/42)) rapidly form amyloid fibrils that cross-seed with full-length Abeta","volume":"16","author":"Tian","year":"2025","journal-title":"Nat. Commun."},{"key":"10.1016\/j.jpsychires.2026.01.050_bib314","doi-asserted-by":"crossref","first-page":"1562","DOI":"10.1002\/glia.23024","article-title":"Inhomogeneous distribution of Iba-1 characterizes microglial pathology in Alzheimer's disease","volume":"64","author":"Tischer","year":"2016","journal-title":"Glia"},{"key":"10.1016\/j.jpsychires.2026.01.050_bib315","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/S0165-5728(01)00496-9","article-title":"Occurrence of T cells in the brain of Alzheimer's disease and other neurological diseases","volume":"124","author":"Togo","year":"2002","journal-title":"J. Neuroimmunol."},{"key":"10.1016\/j.jpsychires.2026.01.050_bib316","doi-asserted-by":"crossref","first-page":"1105","DOI":"10.3233\/JAD-161088","article-title":"Oxidative stress, synaptic dysfunction, and Alzheimer's disease","volume":"57","author":"Tonnies","year":"2017","journal-title":"J. Alzheimers Dis."},{"key":"10.1016\/j.jpsychires.2026.01.050_bib317","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1016\/0006-8993(90)91496-4","article-title":"Reactive microglia express class I and class II major histocompatibility complex antigens in Alzheimer's disease","volume":"523","author":"Tooyama","year":"1990","journal-title":"Brain Res."},{"key":"10.1016\/j.jpsychires.2026.01.050_bib318","doi-asserted-by":"crossref","DOI":"10.3390\/cells12151981","article-title":"The role of cytokines in neutrophil development, tissue homing, function and plasticity in health and disease","volume":"12","author":"Tsioumpekou","year":"2023","journal-title":"Cells"},{"key":"10.1016\/j.jpsychires.2026.01.050_bib319","doi-asserted-by":"crossref","first-page":"575","DOI":"10.3233\/JAD-140741","article-title":"The murine version of BAN2401 (mAb158) selectively reduces amyloid-beta protofibrils in brain and cerebrospinal fluid of tg-ArcSwe mice","volume":"43","author":"Tucker","year":"2015","journal-title":"J. Alzheimers Dis."},{"key":"10.1016\/j.jpsychires.2026.01.050_bib320","doi-asserted-by":"crossref","first-page":"2563","DOI":"10.1016\/j.bbamcr.2014.05.014","article-title":"Cytokines and chemokines: at the crossroads of cell signalling and inflammatory disease","volume":"1843","author":"Turner","year":"2014","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.jpsychires.2026.01.050_bib321","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1111\/nan.12529","article-title":"Invited Review: APOE at the interface of inflammation, neurodegeneration and pathological protein spread in Alzheimer's disease","volume":"45","author":"Tzioras","year":"2019","journal-title":"Neuropathol. Appl. Neurobiol."},{"key":"10.1016\/j.jpsychires.2026.01.050_bib322","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1038\/s41582-018-0072-1","article-title":"TREM2 - a key player in microglial biology and Alzheimer disease","volume":"14","author":"Ulland","year":"2018","journal-title":"Nat. Rev. Neurol."},{"key":"10.1016\/j.jpsychires.2026.01.050_bib323","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1126\/science.291.5504.657","article-title":"Control of synapse number by glia","volume":"291","author":"Ullian","year":"2001","journal-title":"Science"},{"key":"10.1016\/j.jpsychires.2026.01.050_bib324","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/j.bbi.2020.05.070","article-title":"CD8(+) T-cells infiltrate Alzheimer's disease brains and regulate neuronal- and synapse-related gene expression in APP-PS1 transgenic mice","volume":"89","author":"Unger","year":"2020","journal-title":"Brain Behav. Immun."},{"key":"10.1016\/j.jpsychires.2026.01.050_bib325","article-title":"Potential signals of serious risks\/new safety information identified by the FDA Adverse Event Reporting System (FAERS)","year":"2024","journal-title":"FDAgov"},{"key":"10.1016\/j.jpsychires.2026.01.050_bib326","article-title":"United States FDA news release- July 2, 2024: FDA approves treatment for adults with Alzheimer's disease","year":"2024","journal-title":"FDAgov"},{"key":"10.1016\/j.jpsychires.2026.01.050_bib327","article-title":"FDA converts novel alzheimer's disease treatment to traditional approval","year":"2023","journal-title":"FDAgov"},{"key":"10.1016\/j.jpsychires.2026.01.050_bib328","article-title":"FDA grants accelerated approval for alzheimer's drug","year":"2021","journal-title":"FDAgov"},{"key":"10.1016\/j.jpsychires.2026.01.050_bib329","article-title":"CDER drug and biologic calendar year approvals","year":"2024","journal-title":"FDAgov"},{"key":"10.1016\/j.jpsychires.2026.01.050_bib330","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1056\/NEJMoa2212948","article-title":"Lecanemab in early Alzheimer's disease","volume":"388","author":"van Dyck","year":"2023","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.jpsychires.2026.01.050_bib331","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1002\/ana.25508","article-title":"Induction of brain-infiltrating T-bet-expressing B cells in multiple sclerosis","volume":"86","author":"van Langelaar","year":"2019","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.jpsychires.2026.01.050_bib332","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1016\/j.jneuroim.2010.08.005","article-title":"Inflammatory cytokine release of astrocytes in vitro is reduced by all-trans retinoic acid","volume":"229","author":"van Neerven","year":"2010","journal-title":"J. Neuroimmunol."},{"key":"10.1016\/j.jpsychires.2026.01.050_bib333","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1016\/j.cyto.2015.02.007","article-title":"B cells responses and cytokine production are regulated by their immune microenvironment","volume":"74","author":"Vazquez","year":"2015","journal-title":"Cytokine"},{"key":"10.1016\/j.jpsychires.2026.01.050_bib334","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1189\/jlb.3MR0416-204R","article-title":"Danger-associated molecular patterns in Alzheimer's disease","volume":"101","author":"Venegas","year":"2017","journal-title":"J. Leukoc. Biol."},{"key":"10.1016\/j.jpsychires.2026.01.050_bib335","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1038\/nature25158","article-title":"Microglia-derived ASC specks cross-seed amyloid-beta in Alzheimer's disease","volume":"552","author":"Venegas","year":"2017","journal-title":"Nature"},{"key":"10.1016\/j.jpsychires.2026.01.050_bib336","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1016\/j.nurt.2010.05.017","article-title":"Astrocytes in Alzheimer's disease","volume":"7","author":"Verkhratsky","year":"2010","journal-title":"Neurotherapeutics"},{"key":"10.1016\/j.jpsychires.2026.01.050_bib337","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1007\/978-3-030-77375-5_2","article-title":"Astrocytes: the housekeepers and guardians of the CNS","volume":"26","author":"Verkhratsky","year":"2021","journal-title":"Adv. Neurobiol."},{"key":"10.1016\/j.jpsychires.2026.01.050_bib338","doi-asserted-by":"crossref","first-page":"2821","DOI":"10.1038\/s41380-024-02534-4","article-title":"Brain stars take the lead during critical periods of early postnatal brain development: relevance of astrocytes in health and mental disorders","volume":"29","author":"Vivi","year":"2024","journal-title":"Mol. Psychiatr."},{"key":"10.1016\/j.jpsychires.2026.01.050_bib339","doi-asserted-by":"crossref","first-page":"626","DOI":"10.1038\/nrn1722","article-title":"Astrocytes, from brain glue to communication elements: the revolution continues","volume":"6","author":"Volterra","year":"2005","journal-title":"Nat. Rev. Neurosci."},{"key":"10.1016\/j.jpsychires.2026.01.050_bib340","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1111\/j.1752-8062.2009.00121.x","article-title":"Translational medicine lessons from flurizan's failure in Alzheimer's disease (AD) trial: implication for future drug discovery and development for AD","volume":"2","author":"Wan","year":"2009","journal-title":"Clin. Transl. Sci."},{"key":"10.1016\/j.jpsychires.2026.01.050_bib341","first-page":"136","article-title":"Role of pro-inflammatory cytokines released from microglia in Alzheimer's disease","volume":"3","author":"Wang","year":"2015","journal-title":"Ann. Transl. Med."},{"key":"10.1016\/j.jpsychires.2026.01.050_bib342","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1186\/s12974-020-01990-3","article-title":"Correction to: mild endoplasmic reticulum stress ameliorates lipopolysaccharide-induced neuroinflammation and cognitive impairment via regulation of microglial polarization","volume":"17","author":"Wang","year":"2020","journal-title":"J. Neuroinflammation"},{"key":"10.1016\/j.jpsychires.2026.01.050_bib343","doi-asserted-by":"crossref","DOI":"10.1084\/jem.20200785","article-title":"Anti-human TREM2 induces microglia proliferation and reduces pathology in an Alzheimer's disease model","volume":"217","author":"Wang","year":"2020","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.jpsychires.2026.01.050_bib344","doi-asserted-by":"crossref","first-page":"4153","DOI":"10.1016\/j.cell.2022.09.033","article-title":"TREM2 drives microglia response to amyloid-beta via SYK-dependent and -independent pathways","volume":"185","author":"Wang","year":"2022","journal-title":"Cell"},{"key":"10.1016\/j.jpsychires.2026.01.050_bib345","article-title":"Spotlight on pro-inflammatory chemokines: regulators of cellular communication in cognitive impairment","volume":"15","author":"Wang","year":"2024","journal-title":"Front. Immunol."},{"key":"10.1016\/j.jpsychires.2026.01.050_bib346","doi-asserted-by":"crossref","first-page":"4405","DOI":"10.4049\/jimmunol.1201433","article-title":"Prolonged production of reactive oxygen species in response to B cell receptor stimulation promotes B cell activation and proliferation","volume":"189","author":"Wheeler","year":"2012","journal-title":"J. Immunol."},{"key":"10.1016\/j.jpsychires.2026.01.050_bib347","doi-asserted-by":"crossref","first-page":"1634","DOI":"10.1016\/S0149-2918(03)80160-1","article-title":"A review of rivastigmine: a reversible cholinesterase inhibitor","volume":"25","author":"Williams","year":"2003","journal-title":"Clin. Ther."},{"key":"10.1016\/j.jpsychires.2026.01.050_bib348","doi-asserted-by":"crossref","first-page":"1929","DOI":"10.1007\/s12031-022-02047-1","article-title":"Role of chemokines in the development and progression of Alzheimer's disease","volume":"72","author":"Wojcieszak","year":"2022","journal-title":"J. Mol. Neurosci."},{"key":"10.1016\/j.jpsychires.2026.01.050_bib349","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2023.1161850","article-title":"Revisiting the neuroinflammation hypothesis in Alzheimer's disease: a focus on the druggability of current targets","volume":"14","author":"Wong-Guerra","year":"2023","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.jpsychires.2026.01.050_bib351","doi-asserted-by":"crossref","first-page":"10837","DOI":"10.1073\/pnas.162350199","article-title":"Prominent neurodegeneration and increased plaque formation in complement-inhibited Alzheimer's mice","volume":"99","author":"Wyss-Coray","year":"2002","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.jpsychires.2026.01.050_bib352","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1038\/nm838","article-title":"Adult mouse astrocytes degrade amyloid-beta in vitro and in situ","volume":"9","author":"Wyss-Coray","year":"2003","journal-title":"Nat. Med."},{"key":"10.1016\/j.jpsychires.2026.01.050_bib353","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1186\/s13024-022-00547-7","article-title":"Novel App knock-in mouse model shows key features of amyloid pathology and reveals profound metabolic dysregulation of microglia","volume":"17","author":"Xia","year":"2022","journal-title":"Mol. Neurodegener."},{"key":"10.1016\/j.jpsychires.2026.01.050_bib354","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1186\/s12974-018-1074-z","article-title":"Lymphotoxin beta receptor-mediated NFkappaB signaling promotes glial lineage differentiation and inhibits neuronal lineage differentiation in mouse brain neural stem\/progenitor cells","volume":"15","author":"Xiao","year":"2018","journal-title":"J. Neuroinflammation"},{"key":"10.1016\/j.jpsychires.2026.01.050_bib355","doi-asserted-by":"crossref","DOI":"10.1523\/JNEUROSCI.21-01-j0001.2001","article-title":"Amyloid-beta peptides are cytotoxic to oligodendrocytes","volume":"21","author":"Xu","year":"2001","journal-title":"J. Neurosci."},{"key":"10.1016\/j.jpsychires.2026.01.050_bib356","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1186\/s40035-023-00364-y","article-title":"Brain metabolism in Alzheimer's disease: biological mechanisms of exercise","volume":"12","author":"Xu","year":"2023","journal-title":"Transl. Neurodegener."},{"key":"10.1016\/j.jpsychires.2026.01.050_bib357","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/j.cca.2016.02.024","article-title":"Imbalanced cholesterol metabolism in Alzheimer's disease","volume":"456","author":"Xue-Shan","year":"2016","journal-title":"Clin. Chim. Acta"},{"key":"10.1016\/j.jpsychires.2026.01.050_bib358","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1523\/JNEUROSCI.1698-16.2016","article-title":"Large soluble oligomers of amyloid beta-protein from alzheimer brain are far less neuroactive than the smaller oligomers to which they dissociate","volume":"37","author":"Yang","year":"2017","journal-title":"J. Neurosci."},{"key":"10.1016\/j.jpsychires.2026.01.050_bib359","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1111\/imr.12577","article-title":"Alarmins and immunity","volume":"280","author":"Yang","year":"2017","journal-title":"Immunol. Rev."},{"key":"10.1016\/j.jpsychires.2026.01.050_bib360","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1016\/j.jneuroim.2010.07.023","article-title":"In vitro and in vivo induction and activation of nNOS by LPS in oligodendrocytes","volume":"229","author":"Yao","year":"2010","journal-title":"J. Neuroimmunol."},{"key":"10.1016\/j.jpsychires.2026.01.050_bib361","doi-asserted-by":"crossref","first-page":"457","DOI":"10.3389\/fncel.2019.00457","article-title":"Distinct signaling pathways regulate TREM2 phagocytic and NFkappaB antagonistic activities","volume":"13","author":"Yao","year":"2019","journal-title":"Front. Cell. Neurosci."},{"key":"10.1016\/j.jpsychires.2026.01.050_bib362","doi-asserted-by":"crossref","first-page":"880","DOI":"10.1038\/nm.3913","article-title":"Neutrophils promote Alzheimer's disease-like pathology and cognitive decline via LFA-1 integrin","volume":"21","author":"Zenaro","year":"2015","journal-title":"Nat. Med."},{"key":"10.1016\/j.jpsychires.2026.01.050_bib363","doi-asserted-by":"crossref","DOI":"10.1016\/j.nbd.2024.106461","article-title":"T cell infiltration mediates neurodegeneration and cognitive decline in Alzheimer's disease","volume":"193","author":"Zeng","year":"2024","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.jpsychires.2026.01.050_bib364","doi-asserted-by":"crossref","first-page":"8762","DOI":"10.1038\/ncomms9762","article-title":"Delta-secretase cleaves amyloid precursor protein and regulates the pathogenesis in Alzheimer's disease","volume":"6","author":"Zhang","year":"2015","journal-title":"Nat. Commun."},{"key":"10.1016\/j.jpsychires.2026.01.050_bib365","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1038\/s41392-023-01486-5","article-title":"Role of neuroinflammation in neurodegeneration development","volume":"8","author":"Zhang","year":"2023","journal-title":"Signal Transduct. Targeted Ther."},{"key":"10.1016\/j.jpsychires.2026.01.050_bib366","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1038\/s41392-023-01484-7","article-title":"Amyloid beta-based therapy for Alzheimer's disease: challenges, successes and future","volume":"8","author":"Zhang","year":"2023","journal-title":"Signal Transduct. Targeted Ther."},{"key":"10.1016\/j.jpsychires.2026.01.050_bib367","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1038\/s41392-024-01911-3","article-title":"Recent advances in Alzheimer's disease: mechanisms, clinical trials and new drug development strategies","volume":"9","author":"Zhang","year":"2024","journal-title":"Signal Transduct. Targeted Ther."},{"key":"10.1016\/j.jpsychires.2026.01.050_bib368","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1186\/s40035-016-0054-4","article-title":"The dual roles of cytokines in Alzheimer's disease: update on interleukins, TNF-alpha, TGF-beta and IFN-gamma","volume":"5","author":"Zheng","year":"2016","journal-title":"Transl. Neurodegener."},{"key":"10.1016\/j.jpsychires.2026.01.050_bib369","doi-asserted-by":"crossref","first-page":"395","DOI":"10.3389\/fnagi.2018.00395","article-title":"TREM2 in Alzheimer's Disease: microglial survival and energy metabolism","volume":"10","author":"Zheng","year":"2018","journal-title":"Front. Aging Neurosci."},{"key":"10.1016\/j.jpsychires.2026.01.050_bib370","doi-asserted-by":"crossref","first-page":"1794","DOI":"10.1016\/j.immuni.2023.06.016","article-title":"TREM2 receptor protects against complement-mediated synaptic loss by binding to complement C1q during neurodegeneration","volume":"56","author":"Zhong","year":"2023","journal-title":"Immunity"},{"key":"10.1016\/j.jpsychires.2026.01.050_bib371","doi-asserted-by":"crossref","first-page":"202","DOI":"10.3389\/fnagi.2018.00202","article-title":"TREM2-Dependent effects on microglia in Alzheimer's disease","volume":"10","author":"Zhou","year":"2018","journal-title":"Front. Aging Neurosci."}],"container-title":["Journal of Psychiatric Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022395626000610?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022395626000610?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,3,26]],"date-time":"2026-03-26T00:14:40Z","timestamp":1774484080000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0022395626000610"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4]]},"references-count":365,"alternative-id":["S0022395626000610"],"URL":"https:\/\/doi.org\/10.1016\/j.jpsychires.2026.01.050","relation":{},"ISSN":["0022-3956"],"issn-type":[{"value":"0022-3956","type":"print"}],"subject":[],"published":{"date-parts":[[2026,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Microglial, astrocytic, oligodendrocyte, B-\/T-cell and neutrophil dysregulation in neuroinflammation of Alzheimer's disease and related dementias","name":"articletitle","label":"Article Title"},{"value":"Journal of Psychiatric Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jpsychires.2026.01.050","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier Ltd. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}